<div class="_item1_gldt3_1" id="overview">
 <h2 class="_title_gldt3_1">
  <span>
   Overview
  </span>
 </h2>
 <!-- -->
 <div class="_item2_gldt3_15" id="basic">
  <h3 class="_title_gldt3_1">
   <span>
    Basic Info
   </span>
  </h3>
  <div class="_content_gldt3_7">
   <!--[-->
   <div class="ant-descriptions ant-descriptions-middle _middle_l74zf_24 _horizontal_l74zf_18 _drugDetailDirection_19rjs_1">
    <!-- -->
    <div class="ant-descriptions-view">
     <table>
      <tbody>
       <!--[-->
       <tr class="ant-descriptions-row">
        <!--[-->
        <td class="ant-descriptions-item" colspan="1" style="">
         <div class="ant-descriptions-item-container">
          <span class="ant-descriptions-item-label" style="width:190px;">
           <!--[-->
           <span class="_label_l74zf_1" data-testid="descriptions-item__label--summary">
            Summary
           </span>
           <!--]-->
          </span>
          <span class="ant-descriptions-item-content" style="max-width:100%;">
           <!--[-->
           <span class="_content_l74zf_6" data-testid="descriptions-item__value--summary">
            <!--[-->
            <span>
             <!--[-->
             Azithromycin, a small molecule drug, works by targeting the 50S subunit of the bacterial ribosome and disrupting protein synthesis, ultimately leading to bacterial death. This drug falls under the class of macrolide antibiotics and is commonly used to treat a diverse range of bacterial infections, such as respiratory tract infections, skin and soft tissue infections, and sexually transmitted infections. It is also used as a prophylactic treatment for certain opportunistic infections in HIV patients. Azithromycin gained FDA approval in 1991, representing a significant breakthrough in the field of antibiotic development. With its broad-spectrum activity against a wide range of bacterial species, Azithromycin is a valuable tool for healthcare providers in managing bacterial infections. However, the overuse or misuse of antibiotics such as Azithromycin can lead to the emergence of antibiotic-resistant bacteria. Therefore, healthcare providers must exercise caution and prudence when prescribing Azithromycin to prevent the development of antibiotic resistance. Overall, Azithromycin is a potent antibiotic that plays a crucial role in the treatment of bacterial infections.
             <!--]-->
            </span>
            <!--]-->
           </span>
           <!--]-->
          </span>
         </div>
        </td>
        <!--]-->
       </tr>
       <tr class="ant-descriptions-row">
        <!--[-->
        <td class="ant-descriptions-item" colspan="1" style="">
         <div class="ant-descriptions-item-container">
          <span class="ant-descriptions-item-label" style="width:190px;">
           <!--[-->
           <span class="_label_l74zf_1" data-testid="descriptions-item__label--drugType">
            Drug Type
           </span>
           <!--]-->
          </span>
          <span class="ant-descriptions-item-content" style="max-width:100%;">
           <!--[-->
           <span class="_content_l74zf_6" data-testid="descriptions-item__value--drugType">
            <!--[-->
            <span>
             <!--[-->
             <span style="--bdf8c0bc:14px;">
              <!--[-->
              <div class="flex items-center overflow-hidden flex-wrap gap-x-1 gap-y-1">
               <!--[-->
               Small molecule drug
               <!--]-->
               <!-- -->
              </div>
              <!--]-->
             </span>
             <!--]-->
            </span>
            <!--]-->
           </span>
           <!--]-->
          </span>
         </div>
        </td>
        <!--]-->
       </tr>
       <tr class="ant-descriptions-row">
        <!--[-->
        <td class="ant-descriptions-item" colspan="1" style="">
         <div class="ant-descriptions-item-container">
          <span class="ant-descriptions-item-label" style="width:190px;">
           <!--[-->
           <span class="_label_l74zf_1" data-testid="descriptions-item__label--synonyms">
            Synonyms
           </span>
           <!--]-->
          </span>
          <span class="ant-descriptions-item-content" style="max-width:100%;">
           <!--[-->
           <span class="_content_l74zf_6" data-testid="descriptions-item__value--synonyms">
            <!--[-->
            <span>
             <!--[-->
             <span style="--bdf8c0bc:14px;">
              <!--[-->
              <div class="flex items-center overflow-hidden flex-wrap gap-x-1 gap-y-1">
               <!--[-->
               <span>
                Azithromycin (INN),
               </span>
               <span>
                Azithromycin Dihydrate,
               </span>
               <span>
                Azithromycin Hydrate
               </span>
               <!--]-->
               <span class="ml-2 flex flex-shrink-0 items-center">
                <!--[-->
                <div class="inline-flex h-full">
                 <div class="inline-flex max-w-full">
                  <!--[-->
                  <div class="inline-flex cursor-pointer items-center text-yellow-600">
                   <svg class="mr-[2px]" fill="currentColor" height="1.2em" viewbox="0 0 10 16" width="1.2em">
                    <path d="M9.70678 6.27142H5.92999L6.67408 0.15021C6.68107 0.0907286 6.65118 0.0334335 6.60111 0.0103023C6.55104 -0.0128288 6.49315 0.00392205 6.45976 0.0512057L0.0610803 9.20641C-0.00721034 9.30424 -0.0192403 9.43647 0.0300607 9.54737C0.0793617 9.65827 0.181418 9.72854 0.293217 9.72858H4.07001L3.32592 15.8498C3.31893 15.9093 3.34882 15.9666 3.39889 15.9897C3.44896 16.0128 3.50685 15.9961 3.54024 15.9488L9.93892 6.79359C10.0072 6.69576 10.0192 6.56353 9.96994 6.45263C9.92064 6.34174 9.81858 6.27146 9.70678 6.27142Z" fill-rule="evenodd">
                    </path>
                   </svg>
                   <span class="">
                    + [29]
                   </span>
                  </div>
                  <!--]-->
                 </div>
                </div>
                <!--]-->
               </span>
              </div>
              <!--]-->
             </span>
             <!--]-->
            </span>
            <!--]-->
           </span>
           <!--]-->
          </span>
         </div>
        </td>
        <!--]-->
       </tr>
       <tr class="ant-descriptions-row">
        <!--[-->
        <td class="ant-descriptions-item" colspan="1" style="">
         <div class="ant-descriptions-item-container">
          <span class="ant-descriptions-item-label" style="width:190px;">
           <!--[-->
           <span class="_label_l74zf_1" data-testid="descriptions-item__label--target">
            Target
           </span>
           <!--]-->
          </span>
          <span class="ant-descriptions-item-content" style="max-width:100%;">
           <!--[-->
           <span class="_content_l74zf_6" data-testid="descriptions-item__value--target">
            <!--[-->
            <span>
             <!--[-->
             <span style="--bdf8c0bc:14px;">
              <!--[-->
              <div class="flex items-center overflow-hidden flex-wrap gap-x-1 gap-y-1">
               <!--[-->
               <span class="_tag_5lm5p_1 _default_5lm5p_20 _small_5lm5p_31 _entityTag_3wddt_1" data-testid="entity-tag--target" style="background:;color:;">
                <!--[-->
                <!-- -->
                <a class="flex-1 truncate text-black" href="/target/32813993f70c47c396c8954cd5eab46c" rel="noopener" target="_blank">
                 <!--[-->
                 <!--[-->
                 <span class="">
                  50S subunit
                 </span>
                 <!--]-->
                 <!--]-->
                </a>
                <!-- -->
                <!-- -->
                <!--]-->
               </span>
               <!--]-->
               <!-- -->
              </div>
              <!--]-->
             </span>
             <!--]-->
            </span>
            <!--]-->
           </span>
           <!--]-->
          </span>
         </div>
        </td>
        <!--]-->
       </tr>
       <tr class="ant-descriptions-row">
        <!--[-->
        <td class="ant-descriptions-item" colspan="1" style="">
         <div class="ant-descriptions-item-container">
          <span class="ant-descriptions-item-label" style="width:190px;">
           <!--[-->
           <span class="_label_l74zf_1" data-testid="descriptions-item__label--action">
            Action
           </span>
           <!--]-->
          </span>
          <span class="ant-descriptions-item-content" style="max-width:100%;">
           <!--[-->
           <span class="_content_l74zf_6" data-testid="descriptions-item__value--action">
            <!--[-->
            <span>
             <!--[-->
             <span style="--bdf8c0bc:14px;">
              <!--[-->
              <div class="flex items-center overflow-hidden flex-wrap gap-x-1 gap-y-1">
               <!--[-->
               <span>
                inhibitors
               </span>
               <!--]-->
               <!-- -->
              </div>
              <!--]-->
             </span>
             <!--]-->
            </span>
            <!--]-->
           </span>
           <!--]-->
          </span>
         </div>
        </td>
        <!--]-->
       </tr>
       <tr class="ant-descriptions-row">
        <!--[-->
        <td class="ant-descriptions-item" colspan="1" style="">
         <div class="ant-descriptions-item-container">
          <span class="ant-descriptions-item-label" style="width:190px;">
           <!--[-->
           <span class="_label_l74zf_1" data-testid="descriptions-item__label--mechanism">
            Mechanism
           </span>
           <!--]-->
          </span>
          <span class="ant-descriptions-item-content" style="max-width:100%;">
           <!--[-->
           <span class="_content_l74zf_6" data-testid="descriptions-item__value--mechanism">
            <!--[-->
            <span>
             <!--[-->
             <span style="--bdf8c0bc:14px;">
              <!--[-->
              <div class="flex items-center overflow-hidden flex-wrap gap-x-1 gap-y-1">
               <!--[-->
               <span class="">
                50S subunit inhibitors(50S ribosomal subunit inhibitors)
               </span>
               <!--]-->
               <!-- -->
              </div>
              <!--]-->
             </span>
             <!--]-->
            </span>
            <!--]-->
           </span>
           <!--]-->
          </span>
         </div>
        </td>
        <!--]-->
       </tr>
       <tr class="ant-descriptions-row">
        <!--[-->
        <td class="ant-descriptions-item" colspan="1" style="">
         <div class="ant-descriptions-item-container">
          <span class="ant-descriptions-item-label" style="width:190px;">
           <!--[-->
           <span class="_label_l74zf_1" data-testid="descriptions-item__label--therapeutic">
            Therapeutic Areas
           </span>
           <!--]-->
          </span>
          <span class="ant-descriptions-item-content" style="max-width:100%;">
           <!--[-->
           <span class="_content_l74zf_6" data-testid="descriptions-item__value--therapeutic">
            <!--[-->
            <span>
             <!--[-->
             <span style="--bdf8c0bc:14px;">
              <!--[-->
              <div class="flex items-center overflow-hidden flex-wrap gap-x-1 gap-y-1">
               <!--[-->
               <span class="_tag_5lm5p_1 _default_5lm5p_20 _small_5lm5p_31 _entityTag_3wddt_1" data-testid="entity-tag--disease" style="background:;color:;">
                <!--[-->
                <!-- -->
                <a class="flex-1 truncate text-black" href="/disease/9a802adb6e94433f8f4eb9be678991b8" rel="noopener" target="_blank">
                 <!--[-->
                 <!--[-->
                 Infectious Diseases
                 <!--]-->
                 <!--]-->
                </a>
                <!-- -->
                <!-- -->
                <!--]-->
               </span>
               <span class="_tag_5lm5p_1 _default_5lm5p_20 _small_5lm5p_31 _entityTag_3wddt_1" data-testid="entity-tag--disease" style="background:;color:;">
                <!--[-->
                <!-- -->
                <a class="flex-1 truncate text-black" href="/disease/fce2b462d4fa493eb9d82513b9007011" rel="noopener" target="_blank">
                 <!--[-->
                 <!--[-->
                 Eye Diseases
                 <!--]-->
                 <!--]-->
                </a>
                <!-- -->
                <!-- -->
                <!--]-->
               </span>
               <span class="_tag_5lm5p_1 _default_5lm5p_20 _small_5lm5p_31 _entityTag_3wddt_1" data-testid="entity-tag--disease" style="background:;color:;">
                <!--[-->
                <!-- -->
                <a class="flex-1 truncate text-black" href="/disease/5b1dfc2ca8564662860187aef864467d" rel="noopener" target="_blank">
                 <!--[-->
                 <!--[-->
                 Hemic and Lymphatic Diseases
                 <!--]-->
                 <!--]-->
                </a>
                <!-- -->
                <!-- -->
                <!--]-->
               </span>
               <!--]-->
               <span class="ml-2 flex flex-shrink-0 items-center">
                <!--[-->
                <span class="">
                 + [6]
                </span>
                <!--]-->
               </span>
              </div>
              <!--]-->
             </span>
             <!--]-->
            </span>
            <!--]-->
           </span>
           <!--]-->
          </span>
         </div>
        </td>
        <!--]-->
       </tr>
       <tr class="ant-descriptions-row">
        <!--[-->
        <td class="ant-descriptions-item" colspan="1" style="">
         <div class="ant-descriptions-item-container">
          <span class="ant-descriptions-item-label" style="width:190px;">
           <!--[-->
           <span class="_label_l74zf_1" data-testid="descriptions-item__label--activeDisease">
            Active Indication
           </span>
           <!--]-->
          </span>
          <span class="ant-descriptions-item-content" style="max-width:100%;">
           <!--[-->
           <span class="_content_l74zf_6" data-testid="descriptions-item__value--activeDisease">
            <!--[-->
            <span>
             <!--[-->
             <span style="--bdf8c0bc:14px;">
              <!--[-->
              <div class="flex items-center overflow-hidden flex-wrap gap-x-1 gap-y-1">
               <!--[-->
               <span class="_tag_5lm5p_1 _default_5lm5p_20 _small_5lm5p_31 _entityTag_3wddt_1" data-testid="entity-tag--disease" style="background:;color:;">
                <!--[-->
                <!-- -->
                <a class="flex-1 truncate text-black" href="/disease/81d36cea66d94cae9289918496e09f91" rel="noopener" target="_blank">
                 <!--[-->
                 <!--[-->
                 Genital infection
                 <!--]-->
                 <!--]-->
                </a>
                <!-- -->
                <!-- -->
                <!--]-->
               </span>
               <span class="_tag_5lm5p_1 _default_5lm5p_20 _small_5lm5p_31 _entityTag_3wddt_1" data-testid="entity-tag--disease" style="background:;color:;">
                <!--[-->
                <!-- -->
                <a class="flex-1 truncate text-black" href="/disease/478a3554509441e7936078bddfbca593" rel="noopener" target="_blank">
                 <!--[-->
                 <!--[-->
                 Lower Respiratory Tract Infections
                 <!--]-->
                 <!--]-->
                </a>
                <!-- -->
                <!-- -->
                <!--]-->
               </span>
               <span class="_tag_5lm5p_1 _default_5lm5p_20 _small_5lm5p_31 _entityTag_3wddt_1" data-testid="entity-tag--disease" style="background:;color:;">
                <!--[-->
                <!-- -->
                <a class="flex-1 truncate text-black" href="/disease/f7d9acc73f894d759455d8d8996caeb3" rel="noopener" target="_blank">
                 <!--[-->
                 <!--[-->
                 Otitis Media
                 <!--]-->
                 <!--]-->
                </a>
                <!-- -->
                <!-- -->
                <!--]-->
               </span>
               <!--]-->
               <span class="ml-2 flex flex-shrink-0 items-center">
                <!--[-->
                <span class="">
                 + [34]
                </span>
                <!--]-->
               </span>
              </div>
              <!--]-->
             </span>
             <!--]-->
            </span>
            <!--]-->
           </span>
           <!--]-->
          </span>
         </div>
        </td>
        <!--]-->
       </tr>
       <tr class="ant-descriptions-row">
        <!--[-->
        <td class="ant-descriptions-item" colspan="1" style="">
         <div class="ant-descriptions-item-container">
          <span class="ant-descriptions-item-label" style="width:190px;">
           <!--[-->
           <span class="_label_l74zf_1" data-testid="descriptions-item__label--inActiveDisease">
            Inactive Indication
           </span>
           <!--]-->
          </span>
          <span class="ant-descriptions-item-content" style="max-width:100%;">
           <!--[-->
           <span class="_content_l74zf_6" data-testid="descriptions-item__value--inActiveDisease">
            <!--[-->
            <span>
             <!--[-->
             <span style="--bdf8c0bc:14px;">
              <!--[-->
              <div class="flex items-center overflow-hidden flex-wrap gap-x-1 gap-y-1">
               <!--[-->
               <span class="_tag_5lm5p_1 _default_5lm5p_20 _small_5lm5p_31 _entityTag_3wddt_1" data-testid="entity-tag--disease" style="background:;color:;">
                <!--[-->
                <!-- -->
                <a class="flex-1 truncate text-black" href="/disease/10ed4cbd447e4fe6a9dc80e700982ce0" rel="noopener" target="_blank">
                 <!--[-->
                 <!--[-->
                 Acne Vulgaris
                 <!--]-->
                 <!--]-->
                </a>
                <!-- -->
                <!-- -->
                <!--]-->
               </span>
               <span class="_tag_5lm5p_1 _default_5lm5p_20 _small_5lm5p_31 _entityTag_3wddt_1" data-testid="entity-tag--disease" style="background:;color:;">
                <!--[-->
                <!-- -->
                <a class="flex-1 truncate text-black" href="/disease/ae8e6f653866483981475b969413b581" rel="noopener" target="_blank">
                 <!--[-->
                 <!--[-->
                 Acquired Immunodeficiency Syndrome
                 <!--]-->
                 <!--]-->
                </a>
                <!-- -->
                <!-- -->
                <!--]-->
               </span>
               <span class="_tag_5lm5p_1 _default_5lm5p_20 _small_5lm5p_31 _entityTag_3wddt_1" data-testid="entity-tag--disease" style="background:;color:;">
                <!--[-->
                <!-- -->
                <a class="flex-1 truncate text-black" href="/disease/c68f77e3358c4616be843948b5342e45" rel="noopener" target="_blank">
                 <!--[-->
                 <!--[-->
                 acute bacterial conjunctivitis
                 <!--]-->
                 <!--]-->
                </a>
                <!-- -->
                <!-- -->
                <!--]-->
               </span>
               <!--]-->
               <span class="ml-2 flex flex-shrink-0 items-center">
                <!--[-->
                <span class="">
                 + [22]
                </span>
                <!--]-->
               </span>
              </div>
              <!--]-->
             </span>
             <!--]-->
            </span>
            <!--]-->
           </span>
           <!--]-->
          </span>
         </div>
        </td>
        <!--]-->
       </tr>
       <!--]-->
      </tbody>
     </table>
    </div>
   </div>
   <div class="ant-descriptions ant-descriptions-middle _middle_l74zf_24 _horizontal_l74zf_18 _drugDetailDirection_19rjs_1">
    <!-- -->
    <div class="ant-descriptions-view">
     <table>
      <tbody>
       <!--[-->
       <tr class="ant-descriptions-row">
        <!--[-->
        <td class="ant-descriptions-item" colspan="1" style="">
         <div class="ant-descriptions-item-container">
          <span class="ant-descriptions-item-label" style="width:190px;">
           <!--[-->
           <span class="_label_l74zf_1" data-testid="descriptions-item__label--originOrg">
            Originator Organization
           </span>
           <!--]-->
          </span>
          <span class="ant-descriptions-item-content" style="max-width:100%;">
           <!--[-->
           <span class="_content_l74zf_6" data-testid="descriptions-item__value--originOrg">
            <!--[-->
            <span>
             <!--[-->
             <span style="--bdf8c0bc:14px;">
              <!--[-->
              <div class="flex items-center overflow-hidden flex-wrap gap-x-1 gap-y-1">
               <!--[-->
               <span class="_tag_5lm5p_1 _default_5lm5p_20 _small_5lm5p_31 _entityTag_3wddt_1" data-testid="entity-tag--organization" style="background:;color:;">
                <!--[-->
                <span class="mr-1 h-5 w-5 flex-shrink-0">
                 <!--[-->
                 <span class="_avatar_3wddt_11 ant-avatar ant-avatar-square ant-avatar-image" data-testid="ui-avatar" style="width:20px;height:20px;line-height:20px;font-size:18px;">
                  <img alt="Pfizer Inc." src="https://images.crunchbase.com/image/upload/t_cb-default-original/ricb1aqf73vxbqbqzlyw"/>
                 </span>
                 <!--]-->
                </span>
                <a class="flex-1 truncate text-black" href="/organization/9597e75ba30c9958d4331f586407d7cf" rel="noopener" target="_blank">
                 <!--[-->
                 <!--[-->
                 Pfizer Inc.
                 <!--]-->
                 <!--]-->
                </a>
                <!-- -->
                <!-- -->
                <!--]-->
               </span>
               <!--]-->
               <!-- -->
              </div>
              <!--]-->
             </span>
             <!--]-->
            </span>
            <!--]-->
           </span>
           <!--]-->
          </span>
         </div>
        </td>
        <!--]-->
       </tr>
       <tr class="ant-descriptions-row">
        <!--[-->
        <td class="ant-descriptions-item" colspan="1" style="">
         <div class="ant-descriptions-item-container">
          <span class="ant-descriptions-item-label" style="width:190px;">
           <!--[-->
           <span class="_label_l74zf_1" data-testid="descriptions-item__label--activeOrg">
            Active Organization
           </span>
           <!--]-->
          </span>
          <span class="ant-descriptions-item-content" style="max-width:100%;">
           <!--[-->
           <span class="_content_l74zf_6" data-testid="descriptions-item__value--activeOrg">
            <!--[-->
            <span>
             <!--[-->
             <span style="--bdf8c0bc:14px;">
              <!--[-->
              <div class="flex items-center overflow-hidden flex-wrap gap-x-1 gap-y-1">
               <!--[-->
               <span class="_tag_5lm5p_1 _default_5lm5p_20 _small_5lm5p_31 _entityTag_3wddt_1" data-testid="entity-tag--organization" style="background:;color:;">
                <!--[-->
                <span class="mr-1 h-5 w-5 flex-shrink-0">
                 <!--[-->
                 <span class="_avatar_3wddt_11 ant-avatar ant-avatar-square" data-testid="ui-avatar" style="width:20px;height:20px;line-height:20px;font-size:18px;">
                  <span class="ant-avatar-string" style="opacity:0;">
                   <!-- -->
                  </span>
                 </span>
                 <!--]-->
                </span>
                <a class="flex-1 truncate text-black" href="/organization/2ad5d567ba475ef515697f58c289ab6a" rel="noopener" target="_blank">
                 <!--[-->
                 <!--[-->
                 Shinpoong Pharmaceutical Co., Ltd.
                 <!--]-->
                 <!--]-->
                </a>
                <!-- -->
                <!-- -->
                <!--]-->
               </span>
               <span class="_tag_5lm5p_1 _default_5lm5p_20 _small_5lm5p_31 _entityTag_3wddt_1" data-testid="entity-tag--organization" style="background:;color:;">
                <!--[-->
                <span class="mr-1 h-5 w-5 flex-shrink-0">
                 <!--[-->
                 <span class="_avatar_3wddt_11 ant-avatar ant-avatar-square ant-avatar-image" data-testid="ui-avatar" style="width:20px;height:20px;line-height:20px;font-size:18px;">
                  <img alt="Pfizer Japan, Inc." src="https://res.cloudinary.com/crunchbase-production/image/upload/zx9nmzlz5tcsq2109xpr"/>
                 </span>
                 <!--]-->
                </span>
                <a class="flex-1 truncate text-black" href="/organization/cbc43f0e89d7093367a9f6e0feaae567" rel="noopener" target="_blank">
                 <!--[-->
                 <!--[-->
                 Pfizer Japan, Inc.
                 <!--]-->
                 <!--]-->
                </a>
                <!-- -->
                <!-- -->
                <!--]-->
               </span>
               <span class="_tag_5lm5p_1 _default_5lm5p_20 _small_5lm5p_31 _entityTag_3wddt_1" data-testid="entity-tag--organization" style="background:;color:;">
                <!--[-->
                <span class="mr-1 h-5 w-5 flex-shrink-0">
                 <!--[-->
                 <span class="_avatar_3wddt_11 ant-avatar ant-avatar-square" data-testid="ui-avatar" style="width:20px;height:20px;line-height:20px;font-size:18px;">
                  <span class="ant-avatar-string" style="opacity:0;">
                   <!-- -->
                  </span>
                 </span>
                 <!--]-->
                </span>
                <a class="flex-1 truncate text-black" href="/organization/c257611e07561f983bc2c141920c8911" rel="noopener" target="_blank">
                 <!--[-->
                 <!--[-->
                 Jiangxi Yiyou Pharmaceutical Co., Ltd.
                 <!--]-->
                 <!--]-->
                </a>
                <!-- -->
                <!-- -->
                <!--]-->
               </span>
               <!--]-->
               <span class="ml-2 flex flex-shrink-0 items-center">
                <!--[-->
                <div class="inline-flex h-full">
                 <div class="inline-flex max-w-full">
                  <!--[-->
                  <div class="inline-flex cursor-pointer items-center text-yellow-600">
                   <svg class="mr-[2px]" fill="currentColor" height="1.2em" viewbox="0 0 10 16" width="1.2em">
                    <path d="M9.70678 6.27142H5.92999L6.67408 0.15021C6.68107 0.0907286 6.65118 0.0334335 6.60111 0.0103023C6.55104 -0.0128288 6.49315 0.00392205 6.45976 0.0512057L0.0610803 9.20641C-0.00721034 9.30424 -0.0192403 9.43647 0.0300607 9.54737C0.0793617 9.65827 0.181418 9.72854 0.293217 9.72858H4.07001L3.32592 15.8498C3.31893 15.9093 3.34882 15.9666 3.39889 15.9897C3.44896 16.0128 3.50685 15.9961 3.54024 15.9488L9.93892 6.79359C10.0072 6.69576 10.0192 6.56353 9.96994 6.45263C9.92064 6.34174 9.81858 6.27146 9.70678 6.27142Z" fill-rule="evenodd">
                    </path>
                   </svg>
                   <span class="">
                    + [6]
                   </span>
                  </div>
                  <!--]-->
                 </div>
                </div>
                <!--]-->
               </span>
              </div>
              <!--]-->
             </span>
             <!--]-->
            </span>
            <!--]-->
           </span>
           <!--]-->
          </span>
         </div>
        </td>
        <!--]-->
       </tr>
       <tr class="ant-descriptions-row">
        <!--[-->
        <td class="ant-descriptions-item" colspan="1" style="">
         <div class="ant-descriptions-item-container">
          <span class="ant-descriptions-item-label" style="width:190px;">
           <!--[-->
           <span class="_label_l74zf_1" data-testid="descriptions-item__label--inActiveOrg">
            Inactive Organization
           </span>
           <!--]-->
          </span>
          <span class="ant-descriptions-item-content" style="max-width:100%;">
           <!--[-->
           <span class="_content_l74zf_6" data-testid="descriptions-item__value--inActiveOrg">
            <!--[-->
            <span>
             <!--[-->
             <span style="--bdf8c0bc:14px;">
              <!--[-->
              <div class="flex items-center overflow-hidden flex-wrap gap-x-1 gap-y-1">
               <!--[-->
               <span class="_tag_5lm5p_1 _default_5lm5p_20 _small_5lm5p_31 _entityTag_3wddt_1" data-testid="entity-tag--organization" style="background:;color:;">
                <!--[-->
                <span class="mr-1 h-5 w-5 flex-shrink-0">
                 <!--[-->
                 <span class="_avatar_3wddt_11 ant-avatar ant-avatar-square" data-testid="ui-avatar" style="width:20px;height:20px;line-height:20px;font-size:18px;">
                  <span class="ant-avatar-string" style="opacity:0;">
                   <!-- -->
                  </span>
                 </span>
                 <!--]-->
                </span>
                <a class="flex-1 truncate text-black" href="/organization/3edcbd5b3cf248f875f625345e311f8e" rel="noopener" target="_blank">
                 <!--[-->
                 <!--[-->
                 PF Prism CV
                 <!--]-->
                 <!--]-->
                </a>
                <!-- -->
                <!-- -->
                <!--]-->
               </span>
               <span class="_tag_5lm5p_1 _default_5lm5p_20 _small_5lm5p_31 _entityTag_3wddt_1" data-testid="entity-tag--organization" style="background:;color:;">
                <!--[-->
                <span class="mr-1 h-5 w-5 flex-shrink-0">
                 <!--[-->
                 <span class="_avatar_3wddt_11 ant-avatar ant-avatar-square ant-avatar-image" data-testid="ui-avatar" style="width:20px;height:20px;line-height:20px;font-size:18px;">
                  <img alt="Merck Sharp &amp; Dohme Corp." src="https://images.crunchbase.com/image/upload/t_cb-default-original/wbfuwiqhxsdsy2zibsbi"/>
                 </span>
                 <!--]-->
                </span>
                <a class="flex-1 truncate text-black" href="/organization/6632a5800bfb389a90c6b15df46d2020" rel="noopener" target="_blank">
                 <!--[-->
                 <!--[-->
                 Merck Sharp &amp; Dohme Corp.
                 <!--]-->
                 <!--]-->
                </a>
                <!-- -->
                <!-- -->
                <!--]-->
               </span>
               <span class="_tag_5lm5p_1 _default_5lm5p_20 _small_5lm5p_31 _entityTag_3wddt_1" data-testid="entity-tag--organization" style="background:;color:;">
                <!--[-->
                <span class="mr-1 h-5 w-5 flex-shrink-0">
                 <!--[-->
                 <span class="_avatar_3wddt_11 ant-avatar ant-avatar-square" data-testid="ui-avatar" style="width:20px;height:20px;line-height:20px;font-size:18px;">
                  <span class="ant-avatar-string" style="opacity:0;">
                   <!-- -->
                  </span>
                 </span>
                 <!--]-->
                </span>
                <a class="flex-1 truncate text-black" href="/organization/37a34e4e90005b2e161912b553331b05" rel="noopener" target="_blank">
                 <!--[-->
                 <!--[-->
                 Teva Parenteral Medicines, Inc.
                 <!--]-->
                 <!--]-->
                </a>
                <!-- -->
                <!-- -->
                <!--]-->
               </span>
               <!--]-->
               <span class="ml-2 flex flex-shrink-0 items-center">
                <!--[-->
                <div class="inline-flex h-full">
                 <div class="inline-flex max-w-full">
                  <!--[-->
                  <div class="inline-flex cursor-pointer items-center text-yellow-600">
                   <svg class="mr-[2px]" fill="currentColor" height="1.2em" viewbox="0 0 10 16" width="1.2em">
                    <path d="M9.70678 6.27142H5.92999L6.67408 0.15021C6.68107 0.0907286 6.65118 0.0334335 6.60111 0.0103023C6.55104 -0.0128288 6.49315 0.00392205 6.45976 0.0512057L0.0610803 9.20641C-0.00721034 9.30424 -0.0192403 9.43647 0.0300607 9.54737C0.0793617 9.65827 0.181418 9.72854 0.293217 9.72858H4.07001L3.32592 15.8498C3.31893 15.9093 3.34882 15.9666 3.39889 15.9897C3.44896 16.0128 3.50685 15.9961 3.54024 15.9488L9.93892 6.79359C10.0072 6.69576 10.0192 6.56353 9.96994 6.45263C9.92064 6.34174 9.81858 6.27146 9.70678 6.27142Z" fill-rule="evenodd">
                    </path>
                   </svg>
                   <span class="">
                    + [4]
                   </span>
                  </div>
                  <!--]-->
                 </div>
                </div>
                <!--]-->
               </span>
              </div>
              <!--]-->
             </span>
             <!--]-->
            </span>
            <!--]-->
           </span>
           <!--]-->
          </span>
         </div>
        </td>
        <!--]-->
       </tr>
       <tr class="ant-descriptions-row">
        <!--[-->
        <td class="ant-descriptions-item" colspan="1" style="">
         <div class="ant-descriptions-item-container">
          <span class="ant-descriptions-item-label" style="width:190px;">
           <!--[-->
           <span class="_label_l74zf_1" data-testid="descriptions-item__label--globalPhase">
            Drug Highest Phase
           </span>
           <!--]-->
          </span>
          <span class="ant-descriptions-item-content" style="max-width:100%;">
           <!--[-->
           <span class="_content_l74zf_6" data-testid="descriptions-item__value--globalPhase">
            <!--[-->
            <span>
             <!--[-->
             <span class="_tag_5lm5p_1 _primary_5lm5p_10 _small_5lm5p_31 _plain_5lm5p_10" style="background:;color:;">
              <!--[-->
              <span class="">
               Approved
              </span>
              <!--]-->
             </span>
             <!-- -->
             <!--]-->
            </span>
            <!--]-->
           </span>
           <!--]-->
          </span>
         </div>
        </td>
        <!--]-->
       </tr>
       <tr class="ant-descriptions-row">
        <!--[-->
        <td class="ant-descriptions-item" colspan="1" style="">
         <div class="ant-descriptions-item-container">
          <span class="ant-descriptions-item-label" style="width:190px;">
           <!--[-->
           <span class="_label_l74zf_1" data-testid="descriptions-item__label--approvalDate">
            First Approval Date
           </span>
           <!--]-->
          </span>
          <span class="ant-descriptions-item-content" style="max-width:100%;">
           <!--[-->
           <span class="_content_l74zf_6" data-testid="descriptions-item__value--approvalDate">
            <!--[-->
            <div class="flex flex-wrap items-center">
             <span class="mr-1">
              United States (01 Nov 1991),
             </span>
             <span style="--bdf8c0bc:14px;">
              <!--[-->
              <div class="flex items-center overflow-hidden flex-wrap gap-x-1 gap-y-1">
               <!--[-->
               <span class="_tag_5lm5p_1 _default_5lm5p_20 _small_5lm5p_31 _entityTag_3wddt_1 ml-1" data-testid="entity-tag--disease" style="background:;color:;">
                <!--[-->
                <!-- -->
                <a class="flex-1 truncate text-black" href="/disease/9a802adb6e94433f8f4eb9be678991b8" rel="noopener" target="_blank">
                 <!--[-->
                 <!--[-->
                 Infectious Diseases
                 <!--]-->
                 <!--]-->
                </a>
                <!-- -->
                <!-- -->
                <!--]-->
               </span>
               <!--]-->
               <!-- -->
              </div>
              <!--]-->
             </span>
            </div>
            <!--]-->
           </span>
           <!--]-->
          </span>
         </div>
        </td>
        <!--]-->
       </tr>
       <tr class="ant-descriptions-row">
        <!--[-->
        <td class="ant-descriptions-item" colspan="1" style="">
         <div class="ant-descriptions-item-container">
          <span class="ant-descriptions-item-label" style="width:190px;">
           <!--[-->
           <span class="_label_l74zf_1" data-testid="descriptions-item__label--regulation">
            Regulation
           </span>
           <!--]-->
          </span>
          <span class="ant-descriptions-item-content" style="max-width:100%;">
           <!--[-->
           <span class="_content_l74zf_6" data-testid="descriptions-item__value--regulation">
            <!--[-->
            <span>
             <!--[-->
             <!--[-->
             <span>
              Orphan Drug (United States),
             </span>
             <span>
              Priority Review (China),
             </span>
             <span>
              Orphan Drug (Japan)
             </span>
             <!--]-->
             <!--]-->
            </span>
            <!--]-->
           </span>
           <!--]-->
          </span>
         </div>
        </td>
        <!--]-->
       </tr>
       <!--]-->
      </tbody>
     </table>
    </div>
   </div>
   <div class="inline-flex max-w-full mt-4 w-full">
    <div class="_tipsContainer_b7pjb_1 _yellow_b7pjb_30 _tipsBorder_b7pjb_9" dialogtype="common" entrancetype="text" isallinforegister="false" showjumptip="true" size="medium" style="--28c9148e:4px;" type="default">
     <!--[-->
     <!--]-->
     <svg class="h-4 w-[10px]" fill="currentColor" height="1.2em" viewbox="0 0 10 16" width="1.2em">
      <path d="M9.70678 6.27142H5.92999L6.67408 0.15021C6.68107 0.0907286 6.65118 0.0334335 6.60111 0.0103023C6.55104 -0.0128288 6.49315 0.00392205 6.45976 0.0512057L0.0610803 9.20641C-0.00721034 9.30424 -0.0192403 9.43647 0.0300607 9.54737C0.0793617 9.65827 0.181418 9.72854 0.293217 9.72858H4.07001L3.32592 15.8498C3.31893 15.9093 3.34882 15.9666 3.39889 15.9897C3.44896 16.0128 3.50685 15.9961 3.54024 15.9488L9.93892 6.79359C10.0072 6.69576 10.0192 6.56353 9.96994 6.45263C9.92064 6.34174 9.81858 6.27146 9.70678 6.27142Z" fill-rule="evenodd">
      </path>
     </svg>
     <!--[-->
     <span class="_text_b7pjb_17">
      Login to view timeline
     </span>
     <!--]-->
    </div>
   </div>
   <!--]-->
  </div>
 </div>
 <div class="_item2_gldt3_15" id="structure">
  <h3 class="_title_gldt3_1">
   <span>
    Structure/Sequence
   </span>
  </h3>
  <div class="_content_gldt3_7">
   <!--[-->
   <!--[-->
   <div class="ant-descriptions ant-descriptions-middle _middle_l74zf_24 _horizontal_l74zf_18" data-testid="drug-structure">
    <!-- -->
    <div class="ant-descriptions-view">
     <table>
      <tbody>
       <!--[-->
       <tr class="ant-descriptions-row">
        <!--[-->
        <td class="ant-descriptions-item" colspan="1" style="">
         <div class="ant-descriptions-item-container">
          <span class="ant-descriptions-item-label" style="width:190px;">
           <!--[-->
           <span class="_label_l74zf_1" data-testid="descriptions-item__label--formual">
            Molecular Formula
           </span>
           <!--]-->
          </span>
          <span class="ant-descriptions-item-content" style="max-width:100%;">
           <!--[-->
           <span class="_content_l74zf_6" data-testid="descriptions-item__value--formual">
            <!--[-->
            <span>
             <!--[-->
             C38H72N2O12
             <!--]-->
            </span>
            <!--]-->
           </span>
           <!--]-->
          </span>
         </div>
        </td>
        <!--]-->
       </tr>
       <tr class="ant-descriptions-row">
        <!--[-->
        <td class="ant-descriptions-item" colspan="1" style="">
         <div class="ant-descriptions-item-container">
          <span class="ant-descriptions-item-label" style="width:190px;">
           <!--[-->
           <span class="_label_l74zf_1" data-testid="descriptions-item__label--inchiKey">
            InChIKey
           </span>
           <!--]-->
          </span>
          <span class="ant-descriptions-item-content" style="max-width:100%;">
           <!--[-->
           <span class="_content_l74zf_6" data-testid="descriptions-item__value--inchiKey">
            <!--[-->
            <span>
             <!--[-->
             MQTOSJVFKKJCRP-BICOPXKESA-N
             <!--]-->
            </span>
            <!--]-->
           </span>
           <!--]-->
          </span>
         </div>
        </td>
        <!--]-->
       </tr>
       <tr class="ant-descriptions-row">
        <!--[-->
        <td class="ant-descriptions-item" colspan="1" style="">
         <div class="ant-descriptions-item-container">
          <span class="ant-descriptions-item-label" style="width:190px;">
           <!--[-->
           <span class="_label_l74zf_1" data-testid="descriptions-item__label--casNo">
            CAS Registry
           </span>
           <!--]-->
          </span>
          <span class="ant-descriptions-item-content" style="max-width:100%;">
           <!--[-->
           <span class="_content_l74zf_6" data-testid="descriptions-item__value--casNo">
            <!--[-->
            <span>
             <!--[-->
             83905-01-5
             <!--]-->
            </span>
            <!--]-->
           </span>
           <!--]-->
          </span>
         </div>
        </td>
        <!--]-->
       </tr>
       <!--]-->
      </tbody>
     </table>
    </div>
   </div>
   <!-- -->
   <!--]-->
   <!-- -->
   <!-- -->
   <!-- -->
   <!--]-->
  </div>
 </div>
 <div class="_item2_gldt3_15" id="related">
  <h3 class="_title_gldt3_1">
   <span>
    Related
   </span>
  </h3>
  <div class="_content_gldt3_7">
   <!--[-->
   <div>
    <div class="mb-4 break-all text-sm text-black">
     <div class="inline-flex max-w-full">
      <!--[-->
      <span class="cursor-pointer font-semibold text-seo-blue-500 underline" data-testid="related-clinical-count">
       792
      </span>
      <!--]-->
     </div>
     <span>
      Clinical Trials associated with Azithromycin
     </span>
    </div>
    <!--[-->
    <div class="_container_8x5ka_1 _clinicalCard_1rpuv_1" data-testid="clinical-document-card">
     <!-- -->
     <!--[-->
     <div class="_container_afoc1_1 border">
      <div class="_subTitle_afoc1_14">
       <!--[-->
       <div class="flex flex-wrap items-center justify-start">
        <div class="inline-flex max-w-full">
         <div class="_tipsContainer_b7pjb_1 _normal_b7pjb_23" dialogtype="common" entrancetype="text" isallinforegister="false" showjumptip="true" size="medium" style="--28c9148e:4px;" type="default">
          <!--[-->
          <!--]-->
          <!-- -->
          <!--[-->
          <!--[-->
          <span class="text-green-500" data-testid="clinical-document-card__register-number">
           NCT06906757
          </span>
          <!--]-->
          <!--]-->
         </div>
        </div>
        <span class="mx-1 text-grey-450">
         /
        </span>
        <span class="_tag_5lm5p_1 _default_5lm5p_20 _mini_5lm5p_55" data-testid="clinical-study-status" style="background:#FAECDA;color:#A85604;">
         <!--[-->
         <span class="">
          Not yet recruiting
         </span>
         <!--]-->
        </span>
        <span class="_tag_5lm5p_1 _primary_5lm5p_10 _mini_5lm5p_55 _plain_5lm5p_10 ml-1" data-testid="clinical-document-card__phase" style="background:;color:;">
         <!--[-->
         <span class="">
          Not Applicable
         </span>
         <!--]-->
        </span>
        <span class="_tag_5lm5p_1 _default_5lm5p_20 _mini_5lm5p_55 ml-1" data-testid="clinical-document-card__itt" style="background:;color:;">
         <!--[-->
         IIT
         <!--]-->
        </span>
       </div>
       <!--]-->
      </div>
      <div class="mt-2 flex items-start">
       <div class="flex-1 overflow-hidden">
        <div class="flex">
         <div>
          <div class="_title_afoc1_6">
           <!--[-->
           <div class="inline-flex max-w-full">
            <div class="_tipsContainer_b7pjb_1 _normal_b7pjb_23" dialogtype="common" entrancetype="text" isallinforegister="false" showjumptip="true" size="medium" style="--28c9148e:4px;" type="default">
             <!--[-->
             <!--]-->
             <!-- -->
             <!--[-->
             <!--[-->
             <span class="_title_1rpuv_1" data-testid="clinical-document-card__title">
              Preterm Rupture of Membranes Optimising Antibiotics Trial (PROMOAT). A Pregnancy Domain Within PLATIPUS.
             </span>
             <!--]-->
             <!--]-->
            </div>
           </div>
           <!--]-->
          </div>
          <!--[-->
          <!--]-->
         </div>
         <!-- -->
        </div>
        <div class="_content_afoc1_31">
         <!--[-->
         <!-- -->
         <div>
          <div class="_container_16a6u_1 _containerStyle_16a6u_7 hidden md:block" style="--374e759f:60px;--661d8904:#1976d2;--470d35e6:20px;--78a7937a:20px;--cab18e14:#1976d2;--324c64a8:#1976d2;--8277a0b4:0px;">
           <div>
            <!--[-->
            <div>
             The goal of this clinical trial is to learn which antibiotic regimen works best to prevent infection in pregnant women whose waters break early (preterm, pre-labour rupture of membranes, or PPROM) and assess the health outcomes of babies born to pregnant women who have received these antibiotics.
             <br/>
             PROMOAT aims to answer the question: Which antibiotic or combined antibiotic regimen most effectively prevents infection in pregnant women with PPROM &lt; 37+0 weeks' gestation.
             <br/>
             Researchers will compare three antibiotic regimens already used in clinical practice to prevent infection in pregnant women with PPROM.
             <br/>
             Participants will be randomly allocated to the antibiotic regimen they will follow for seven days, or until birth (whichever is earlier). All antibiotics will be taken orally.
             <br/>
             Neonatal health outcomes will be collected at 42 weeks postmenstrual age and maternal birth and postpartum care outcomes assessed at 42 days postpartum.
             <br/>
             Questionnaires will capture maternal mood at time of consent and at 42 days postpartum. Antibiotic tolerance will be assessed at the time antibiotic treatment is ceased.
             <br/>
             This trial will be undertaken as part of the PLATIPUS trial (NCT06461429).
            </div>
            <!--]-->
           </div>
           <!-- -->
          </div>
          <!-- -->
          <div class="ant-descriptions ant-descriptions-small _small_l74zf_21 _horizontal_l74zf_18 mt-2 hidden md:block">
           <!-- -->
           <div class="ant-descriptions-view">
            <table>
             <tbody>
              <!--[-->
              <tr class="ant-descriptions-row">
               <!--[-->
               <td class="ant-descriptions-item" colspan="1" style="">
                <div class="ant-descriptions-item-container">
                 <span class="ant-descriptions-item-label" style="width:auto;">
                  <!--[-->
                  <span class="_label_l74zf_1" data-testid="descriptions-item__label--startDate">
                   Start Date
                  </span>
                  <!--]-->
                 </span>
                 <span class="ant-descriptions-item-content" style="max-width:100%;">
                  <!--[-->
                  <span class="_content_l74zf_6" data-testid="descriptions-item__value--startDate">
                   <!--[-->
                   <span class="text-grey-1100" data-testid="clinical-document-card__start-date">
                    01 Sep 2025
                   </span>
                   <!--]-->
                  </span>
                  <!--]-->
                 </span>
                </div>
               </td>
               <!--]-->
              </tr>
              <tr class="ant-descriptions-row">
               <!--[-->
               <td class="ant-descriptions-item" colspan="1" style="">
                <div class="ant-descriptions-item-container">
                 <span class="ant-descriptions-item-label" style="width:auto;">
                  <!--[-->
                  <span class="_label_l74zf_1" data-testid="descriptions-item__label--sponsor">
                   Sponsor / Collaborator
                  </span>
                  <!--]-->
                 </span>
                 <span class="ant-descriptions-item-content" style="max-width:100%;">
                  <!--[-->
                  <span class="_content_l74zf_6" data-testid="descriptions-item__value--sponsor">
                   <!--[-->
                   <span style="--bdf8c0bc:14px;">
                    <!--[-->
                    <div class="flex items-center overflow-hidden flex-wrap gap-x-1 gap-y-1">
                     <!--[-->
                     <!--[-->
                     <span class="_tag_5lm5p_1 _default_5lm5p_20 _small_5lm5p_31 _entityTag_3wddt_1" data-testid="entity-tag--organization" style="background:;color:;">
                      <!--[-->
                      <span class="mr-1 h-5 w-5 flex-shrink-0">
                       <!--[-->
                       <span class="_avatar_3wddt_11 ant-avatar ant-avatar-square ant-avatar-image" data-testid="ui-avatar" style="width:20px;height:20px;line-height:20px;font-size:18px;">
                        <img alt="University of Melbourne" src="https://images.crunchbase.com/image/upload/t_cb-default-original/v1411276706/tv58fdnoxknqqiczuozp.jpg"/>
                       </span>
                       <!--]-->
                      </span>
                      <a class="flex-1 truncate text-black" href="/organization/6429a8e97488dcdb4a9b0d1abb677f1a" rel="noopener" target="_blank">
                       <!--[-->
                       <!--[-->
                       University of Melbourne
                       <!--]-->
                       <!--]-->
                      </a>
                      <!-- -->
                      <!-- -->
                      <!--]-->
                     </span>
                     <!--]-->
                     <!--]-->
                     <!-- -->
                    </div>
                    <!--]-->
                   </span>
                   <!--]-->
                  </span>
                  <!--]-->
                 </span>
                </div>
               </td>
               <!--]-->
              </tr>
              <!--]-->
             </tbody>
            </table>
           </div>
          </div>
         </div>
         <!--]-->
        </div>
       </div>
      </div>
     </div>
     <!--]-->
    </div>
    <div class="_container_8x5ka_1 _clinicalCard_1rpuv_1 mt-3" data-testid="clinical-document-card">
     <!-- -->
     <!--[-->
     <div class="_container_afoc1_1 border">
      <div class="_subTitle_afoc1_14">
       <!--[-->
       <div class="flex flex-wrap items-center justify-start">
        <div class="inline-flex max-w-full">
         <div class="_tipsContainer_b7pjb_1 _normal_b7pjb_23" dialogtype="common" entrancetype="text" isallinforegister="false" showjumptip="true" size="medium" style="--28c9148e:4px;" type="default">
          <!--[-->
          <!--]-->
          <!-- -->
          <!--[-->
          <!--[-->
          <span class="text-green-500" data-testid="clinical-document-card__register-number">
           NCT06921525
          </span>
          <!--]-->
          <!--]-->
         </div>
        </div>
        <span class="mx-1 text-grey-450">
         /
        </span>
        <span class="_tag_5lm5p_1 _default_5lm5p_20 _mini_5lm5p_55" data-testid="clinical-study-status" style="background:#FAECDA;color:#A85604;">
         <!--[-->
         <span class="">
          Not yet recruiting
         </span>
         <!--]-->
        </span>
        <span class="_tag_5lm5p_1 _primary_5lm5p_10 _mini_5lm5p_55 _plain_5lm5p_10 ml-1" data-testid="clinical-document-card__phase" style="background:;color:;">
         <!--[-->
         <span class="">
          Phase 1/2
         </span>
         <!--]-->
        </span>
        <span class="_tag_5lm5p_1 _default_5lm5p_20 _mini_5lm5p_55 ml-1" data-testid="clinical-document-card__itt" style="background:;color:;">
         <!--[-->
         IIT
         <!--]-->
        </span>
       </div>
       <!--]-->
      </div>
      <div class="mt-2 flex items-start">
       <div class="flex-1 overflow-hidden">
        <div class="flex">
         <div>
          <div class="_title_afoc1_6">
           <!--[-->
           <div class="inline-flex max-w-full">
            <div class="_tipsContainer_b7pjb_1 _normal_b7pjb_23" dialogtype="common" entrancetype="text" isallinforegister="false" showjumptip="true" size="medium" style="--28c9148e:4px;" type="default">
             <!--[-->
             <!--]-->
             <!-- -->
             <!--[-->
             <!--[-->
             <span class="_title_1rpuv_1" data-testid="clinical-document-card__title">
              Comparing Efficacy of Tea Tree Oil Versus Topical Azithromycin in Treating Dry Eye Disease Associated With Meibomian Gland Dysfunction: A Focus on Tear Interleukin Level
             </span>
             <!--]-->
             <!--]-->
            </div>
           </div>
           <!--]-->
          </div>
          <!--[-->
          <!--]-->
         </div>
         <!-- -->
        </div>
        <div class="_content_afoc1_31">
         <!--[-->
         <!-- -->
         <div>
          <div class="_container_16a6u_1 _containerStyle_16a6u_7 hidden md:block" style="--374e759f:60px;--661d8904:#1976d2;--470d35e6:20px;--78a7937a:20px;--cab18e14:#1976d2;--324c64a8:#1976d2;--8277a0b4:0px;">
           <div>
            <!--[-->
            <div>
             This study aims to compare the effects of azithromycin and tea tree oil on the clinical outcomes and inflammatory profile of patients with MGD-associated DED. By focusing on changes in tear IL-8 and IL-17 levels, the study seeks to provide insights into the differential mechanisms of these two treatments and their potential in addressing inflammation-driven DED.
            </div>
            <!--]-->
           </div>
           <!-- -->
          </div>
          <!-- -->
          <div class="ant-descriptions ant-descriptions-small _small_l74zf_21 _horizontal_l74zf_18 mt-2 hidden md:block">
           <!-- -->
           <div class="ant-descriptions-view">
            <table>
             <tbody>
              <!--[-->
              <tr class="ant-descriptions-row">
               <!--[-->
               <td class="ant-descriptions-item" colspan="1" style="">
                <div class="ant-descriptions-item-container">
                 <span class="ant-descriptions-item-label" style="width:auto;">
                  <!--[-->
                  <span class="_label_l74zf_1" data-testid="descriptions-item__label--startDate">
                   Start Date
                  </span>
                  <!--]-->
                 </span>
                 <span class="ant-descriptions-item-content" style="max-width:100%;">
                  <!--[-->
                  <span class="_content_l74zf_6" data-testid="descriptions-item__value--startDate">
                   <!--[-->
                   <span class="text-grey-1100" data-testid="clinical-document-card__start-date">
                    01 Apr 2025
                   </span>
                   <!--]-->
                  </span>
                  <!--]-->
                 </span>
                </div>
               </td>
               <!--]-->
              </tr>
              <tr class="ant-descriptions-row">
               <!--[-->
               <td class="ant-descriptions-item" colspan="1" style="">
                <div class="ant-descriptions-item-container">
                 <span class="ant-descriptions-item-label" style="width:auto;">
                  <!--[-->
                  <span class="_label_l74zf_1" data-testid="descriptions-item__label--sponsor">
                   Sponsor / Collaborator
                  </span>
                  <!--]-->
                 </span>
                 <span class="ant-descriptions-item-content" style="max-width:100%;">
                  <!--[-->
                  <span class="_content_l74zf_6" data-testid="descriptions-item__value--sponsor">
                   <!--[-->
                   <span style="--bdf8c0bc:14px;">
                    <!--[-->
                    <div class="flex items-center overflow-hidden flex-wrap gap-x-1 gap-y-1">
                     <!--[-->
                     <!--[-->
                     <span class="_tag_5lm5p_1 _default_5lm5p_20 _small_5lm5p_31 _entityTag_3wddt_1" data-testid="entity-tag--organization" style="background:;color:;">
                      <!--[-->
                      <span class="mr-1 h-5 w-5 flex-shrink-0">
                       <!--[-->
                       <span class="_avatar_3wddt_11 ant-avatar ant-avatar-square ant-avatar-image" data-testid="ui-avatar" style="width:20px;height:20px;line-height:20px;font-size:18px;">
                        <img alt="Benha University" src="https://res.cloudinary.com/crunchbase-production/image/upload/s4hjzbpbzsblpixajymx"/>
                       </span>
                       <!--]-->
                      </span>
                      <a class="flex-1 truncate text-black" href="/organization/2e6b6915d0e96ba9327c3597c520a89c" rel="noopener" target="_blank">
                       <!--[-->
                       <!--[-->
                       Benha University
                       <!--]-->
                       <!--]-->
                      </a>
                      <!-- -->
                      <!-- -->
                      <!--]-->
                     </span>
                     <!--]-->
                     <!--]-->
                     <span class="ml-2 flex flex-shrink-0 items-center">
                      <!--[-->
                      <div class="inline-flex max-w-full">
                       <div class="_tipsContainer_b7pjb_1 _yellow_b7pjb_30" dialogtype="common" entrancetype="text" isallinforegister="false" showjumptip="true" size="medium" style="--28c9148e:4px;" type="default">
                        <!--[-->
                        <!--]-->
                        <svg class="h-4 w-[10px]" fill="currentColor" height="1.2em" viewbox="0 0 10 16" width="1.2em">
                         <path d="M9.70678 6.27142H5.92999L6.67408 0.15021C6.68107 0.0907286 6.65118 0.0334335 6.60111 0.0103023C6.55104 -0.0128288 6.49315 0.00392205 6.45976 0.0512057L0.0610803 9.20641C-0.00721034 9.30424 -0.0192403 9.43647 0.0300607 9.54737C0.0793617 9.65827 0.181418 9.72854 0.293217 9.72858H4.07001L3.32592 15.8498C3.31893 15.9093 3.34882 15.9666 3.39889 15.9897C3.44896 16.0128 3.50685 15.9961 3.54024 15.9488L9.93892 6.79359C10.0072 6.69576 10.0192 6.56353 9.96994 6.45263C9.92064 6.34174 9.81858 6.27146 9.70678 6.27142Z" fill-rule="evenodd">
                         </path>
                        </svg>
                        <!--[-->
                        <!--[-->
                        <span class="ml-1 text-sm text-yellow-600">
                         [+1]
                        </span>
                        <!--]-->
                        <!--]-->
                       </div>
                      </div>
                      <!--]-->
                     </span>
                    </div>
                    <!--]-->
                   </span>
                   <!--]-->
                  </span>
                  <!--]-->
                 </span>
                </div>
               </td>
               <!--]-->
              </tr>
              <!--]-->
             </tbody>
            </table>
           </div>
          </div>
         </div>
         <!--]-->
        </div>
       </div>
      </div>
     </div>
     <!--]-->
    </div>
    <div class="_container_8x5ka_1 _clinicalCard_1rpuv_1 mt-3" data-testid="clinical-document-card">
     <!-- -->
     <!--[-->
     <div class="_container_afoc1_1 border">
      <div class="_subTitle_afoc1_14">
       <!--[-->
       <div class="flex flex-wrap items-center justify-start">
        <div class="inline-flex max-w-full">
         <div class="_tipsContainer_b7pjb_1 _normal_b7pjb_23" dialogtype="common" entrancetype="text" isallinforegister="false" showjumptip="true" size="medium" style="--28c9148e:4px;" type="default">
          <!--[-->
          <!--]-->
          <!-- -->
          <!--[-->
          <!--[-->
          <span class="text-green-500" data-testid="clinical-document-card__register-number">
           ChiCTR2500099459
          </span>
          <!--]-->
          <!--]-->
         </div>
        </div>
        <span class="mx-1 text-grey-450">
         /
        </span>
        <span class="_tag_5lm5p_1 _default_5lm5p_20 _mini_5lm5p_55" data-testid="clinical-study-status" style="background:#FCEDEF;color:#D11A32;">
         <!--[-->
         <span class="">
          Suspended
         </span>
         <!--]-->
        </span>
        <span class="_tag_5lm5p_1 _primary_5lm5p_10 _mini_5lm5p_55 _plain_5lm5p_10 ml-1" data-testid="clinical-document-card__phase" style="background:;color:;">
         <!--[-->
         <span class="">
          Not Applicable
         </span>
         <!--]-->
        </span>
        <span class="_tag_5lm5p_1 _default_5lm5p_20 _mini_5lm5p_55 ml-1" data-testid="clinical-document-card__itt" style="background:;color:;">
         <!--[-->
         IIT
         <!--]-->
        </span>
       </div>
       <!--]-->
      </div>
      <div class="mt-2 flex items-start">
       <div class="flex-1 overflow-hidden">
        <div class="flex">
         <div>
          <div class="_title_afoc1_6">
           <!--[-->
           <div class="inline-flex max-w-full">
            <div class="_tipsContainer_b7pjb_1 _normal_b7pjb_23" dialogtype="common" entrancetype="text" isallinforegister="false" showjumptip="true" size="medium" style="--28c9148e:4px;" type="default">
             <!--[-->
             <!--]-->
             <!-- -->
             <!--[-->
             <!--[-->
             <span class="_title_1rpuv_1" data-testid="clinical-document-card__title">
              Clinical effect of azithromycin combined with budesonide suspension nebulized inhalation in the treatment of Mycoplasma pneumoniae pneumonia in children
             </span>
             <!--]-->
             <!--]-->
            </div>
           </div>
           <!--]-->
          </div>
          <!--[-->
          <!--]-->
         </div>
         <!-- -->
        </div>
        <div class="_content_afoc1_31">
         <!--[-->
         <!-- -->
         <div>
          <!-- -->
          <!-- -->
          <div class="ant-descriptions ant-descriptions-small _small_l74zf_21 _horizontal_l74zf_18 mt-2 hidden md:block">
           <!-- -->
           <div class="ant-descriptions-view">
            <table>
             <tbody>
              <!--[-->
              <tr class="ant-descriptions-row">
               <!--[-->
               <td class="ant-descriptions-item" colspan="1" style="">
                <div class="ant-descriptions-item-container">
                 <span class="ant-descriptions-item-label" style="width:auto;">
                  <!--[-->
                  <span class="_label_l74zf_1" data-testid="descriptions-item__label--startDate">
                   Start Date
                  </span>
                  <!--]-->
                 </span>
                 <span class="ant-descriptions-item-content" style="max-width:100%;">
                  <!--[-->
                  <span class="_content_l74zf_6" data-testid="descriptions-item__value--startDate">
                   <!--[-->
                   <span class="text-grey-1100" data-testid="clinical-document-card__start-date">
                    24 Mar 2025
                   </span>
                   <!--]-->
                  </span>
                  <!--]-->
                 </span>
                </div>
               </td>
               <!--]-->
              </tr>
              <tr class="ant-descriptions-row">
               <!--[-->
               <td class="ant-descriptions-item" colspan="1" style="">
                <div class="ant-descriptions-item-container">
                 <span class="ant-descriptions-item-label" style="width:auto;">
                  <!--[-->
                  <span class="_label_l74zf_1" data-testid="descriptions-item__label--sponsor">
                   Sponsor / Collaborator
                  </span>
                  <!--]-->
                 </span>
                 <span class="ant-descriptions-item-content" style="max-width:100%;">
                  <!--[-->
                  <span class="_content_l74zf_6" data-testid="descriptions-item__value--sponsor">
                   <!--[-->
                   <span style="--bdf8c0bc:14px;">
                    <!--[-->
                    -
                    <!--]-->
                   </span>
                   <!--]-->
                  </span>
                  <!--]-->
                 </span>
                </div>
               </td>
               <!--]-->
              </tr>
              <!--]-->
             </tbody>
            </table>
           </div>
          </div>
         </div>
         <!--]-->
        </div>
       </div>
      </div>
     </div>
     <!--]-->
    </div>
    <!--]-->
   </div>
   <div class="mt-10 md:mt-12">
    <div class="mb-4 break-all text-sm text-black">
     <!--[-->
     <span class="_mosaic_dzucl_1">
      <!--[-->
      <span class="font-semibold text-seo-blue-500 underline">
       100
      </span>
      <!--]-->
     </span>
     <!--]-->
     <span>
      Clinical Results associated with Azithromycin
     </span>
    </div>
    <div class="inline-flex max-w-full mt-4 w-full">
     <div class="_tipsContainer_b7pjb_1 _yellow_b7pjb_30 _tipsBorder_b7pjb_9" dialogtype="common" entrancetype="text" isallinforegister="false" showjumptip="true" size="medium" style="--28c9148e:4px;" type="default">
      <!--[-->
      <!--]-->
      <svg class="h-4 w-[10px]" fill="currentColor" height="1.2em" viewbox="0 0 10 16" width="1.2em">
       <path d="M9.70678 6.27142H5.92999L6.67408 0.15021C6.68107 0.0907286 6.65118 0.0334335 6.60111 0.0103023C6.55104 -0.0128288 6.49315 0.00392205 6.45976 0.0512057L0.0610803 9.20641C-0.00721034 9.30424 -0.0192403 9.43647 0.0300607 9.54737C0.0793617 9.65827 0.181418 9.72854 0.293217 9.72858H4.07001L3.32592 15.8498C3.31893 15.9093 3.34882 15.9666 3.39889 15.9897C3.44896 16.0128 3.50685 15.9961 3.54024 15.9488L9.93892 6.79359C10.0072 6.69576 10.0192 6.56353 9.96994 6.45263C9.92064 6.34174 9.81858 6.27146 9.70678 6.27142Z" fill-rule="evenodd">
       </path>
      </svg>
      <!--[-->
      <span class="_text_b7pjb_17">
       Login to view more data
      </span>
      <!--]-->
     </div>
    </div>
   </div>
   <div class="mt-10 md:mt-12">
    <div class="mb-4 break-all text-sm text-black">
     <!--[-->
     <span class="_mosaic_dzucl_1">
      <!--[-->
      <span class="font-semibold text-seo-blue-500 underline">
       100
      </span>
      <!--]-->
     </span>
     <!--]-->
     <span>
      Translational Medicine associated with Azithromycin
     </span>
    </div>
    <div class="inline-flex max-w-full mt-4 w-full">
     <div class="_tipsContainer_b7pjb_1 _yellow_b7pjb_30 _tipsBorder_b7pjb_9" dialogtype="common" entrancetype="text" isallinforegister="false" showjumptip="true" size="medium" style="--28c9148e:4px;" type="default">
      <!--[-->
      <!--]-->
      <svg class="h-4 w-[10px]" fill="currentColor" height="1.2em" viewbox="0 0 10 16" width="1.2em">
       <path d="M9.70678 6.27142H5.92999L6.67408 0.15021C6.68107 0.0907286 6.65118 0.0334335 6.60111 0.0103023C6.55104 -0.0128288 6.49315 0.00392205 6.45976 0.0512057L0.0610803 9.20641C-0.00721034 9.30424 -0.0192403 9.43647 0.0300607 9.54737C0.0793617 9.65827 0.181418 9.72854 0.293217 9.72858H4.07001L3.32592 15.8498C3.31893 15.9093 3.34882 15.9666 3.39889 15.9897C3.44896 16.0128 3.50685 15.9961 3.54024 15.9488L9.93892 6.79359C10.0072 6.69576 10.0192 6.56353 9.96994 6.45263C9.92064 6.34174 9.81858 6.27146 9.70678 6.27142Z" fill-rule="evenodd">
       </path>
      </svg>
      <!--[-->
      <span class="_text_b7pjb_17">
       Login to view more data
      </span>
      <!--]-->
     </div>
    </div>
   </div>
   <div class="mt-10 md:mt-12">
    <div class="mb-4 break-all text-sm text-black">
     <!--[-->
     <span class="_mosaic_dzucl_1">
      <!--[-->
      <span class="font-semibold text-seo-blue-500 underline">
       100
      </span>
      <!--]-->
     </span>
     <!--]-->
     <span>
      Patents (Medical) associated with Azithromycin
     </span>
    </div>
    <div class="inline-flex max-w-full mt-4 w-full">
     <div class="_tipsContainer_b7pjb_1 _yellow_b7pjb_30 _tipsBorder_b7pjb_9" dialogtype="common" entrancetype="text" isallinforegister="false" showjumptip="true" size="medium" style="--28c9148e:4px;" type="default">
      <!--[-->
      <!--]-->
      <svg class="h-4 w-[10px]" fill="currentColor" height="1.2em" viewbox="0 0 10 16" width="1.2em">
       <path d="M9.70678 6.27142H5.92999L6.67408 0.15021C6.68107 0.0907286 6.65118 0.0334335 6.60111 0.0103023C6.55104 -0.0128288 6.49315 0.00392205 6.45976 0.0512057L0.0610803 9.20641C-0.00721034 9.30424 -0.0192403 9.43647 0.0300607 9.54737C0.0793617 9.65827 0.181418 9.72854 0.293217 9.72858H4.07001L3.32592 15.8498C3.31893 15.9093 3.34882 15.9666 3.39889 15.9897C3.44896 16.0128 3.50685 15.9961 3.54024 15.9488L9.93892 6.79359C10.0072 6.69576 10.0192 6.56353 9.96994 6.45263C9.92064 6.34174 9.81858 6.27146 9.70678 6.27142Z" fill-rule="evenodd">
       </path>
      </svg>
      <!--[-->
      <span class="_text_b7pjb_17">
       Login to view more data
      </span>
      <!--]-->
     </div>
    </div>
   </div>
   <div class="mt-10 md:mt-12">
    <div class="mb-4 break-all text-sm text-black">
     <div class="inline-flex max-w-full">
      <!--[-->
      <span class="cursor-pointer font-semibold text-seo-blue-500 underline" data-testid="related-paper-count">
       24,420
      </span>
      <!--]-->
     </div>
     <span>
      Literatures (Medical) associated with Azithromycin
     </span>
    </div>
    <!--[-->
    <div class="_container_8x5ka_1 _literatureCard_nf4fx_1" data-testid="literature-document-card">
     <!-- -->
     <!--[-->
     <div class="_container_afoc1_1 border">
      <div class="_subTitle_afoc1_14">
       <!--[-->
       <div class="flex flex-col flex-wrap md:flex-row md:items-center md:justify-start">
        <span data-testid="literature-document-card__publication-data">
         31 Dec 2025
        </span>
        <span class="mx-1 hidden md:block">
         ·
        </span>
        <span class="mr-2 text-black" data-testid="literature-document-card__journal-name">
         Emerging Microbes &amp; Infections
        </span>
        <!-- -->
       </div>
       <!--]-->
      </div>
      <div class="mt-2 flex items-start">
       <div class="flex-1 overflow-hidden">
        <div class="flex">
         <div>
          <div class="_title_afoc1_6">
           <!--[-->
           <div class="inline-flex max-w-full">
            <div class="_tipsContainer_b7pjb_1 _normal_b7pjb_23" dialogtype="common" entrancetype="text" isallinforegister="false" showjumptip="true" size="medium" style="--28c9148e:4px;" type="default">
             <!--[-->
             <!--]-->
             <!-- -->
             <!--[-->
             <!--[-->
             <span class="_title_nf4fx_1" data-testid="literature-document-card__title">
              Construction and validation of a predictive model for meningoencephalitis in pediatric scrub typhus based on machine learning algorithms
             </span>
             <!--]-->
             <!--]-->
            </div>
           </div>
           <!--]-->
          </div>
          <!--[-->
          <!--]-->
         </div>
         <!-- -->
        </div>
        <div class="_content_afoc1_31">
         <!--[-->
         <div class="md:hidden">
          <!-- -->
         </div>
         <div class="hidden md:block">
          <div class="flex">
           <span class="_tag_5lm5p_1 _default_5lm5p_20 _small_5lm5p_31 mr-2" style="background:#EDF8FF;color:#0170BD;">
            <!--[-->
            Article
            <!--]-->
           </span>
           <!-- -->
          </div>
          <div class="mt-3 line-clamp-3" data-testid="literature-document-card__author">
           Author:
           <!--[-->
           <span>
            Yang, Xiaotao
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Zou, Xiu
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Wang, Yanchun
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Ding, Wenrui
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Bai, Houxi
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Zhang, Ting
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Jiao, Feng
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Luo, Yonghan
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Guo, Yan
            <!-- -->
           </span>
           <!--]-->
          </div>
          <div class="_container_16a6u_1 _containerStyle_16a6u_7 mt-3" data-testid="literature-document-card__abstract" style="--374e759f:100px;--661d8904:#1976d2;--470d35e6:20px;--78a7937a:20px;--cab18e14:#1976d2;--324c64a8:#1976d2;--8277a0b4:0px;">
           <div>
            <!--[-->
            <!--[-->
            <div class="text-text-t2 whitespace-pre-wrap break-words text-sm leading-5">
             <span class="float-left mr-1">
             </span>
             <div class="text-black-default text-sm" style="word-break:break-word;">
              To retrospectively analyze the clinical characteristics of pediatric scrub typhus (ST) with meningoencephalitis (STME) and to construct and validate predictive models using machine learning.Clinical data were collected from 100 cases of pediatric STME and matched with data from 100 ST cases without meningitis using propensity-score matching. Risk factors for STME in pediatrics were identified through the least absolute shrinkage and selection operator (LASSO) regression analysis. Six predictive models-Logistic Regression, K-Nearest Neighbors, Naive Bayes, Multi-layer Perceptron(MLP), Random Forest, and XGBoost-were constructed using the training set and evaluated for performance, with validation conducted on the test set. The Shapley Additive Explanations (SHAP) method was applied to rank the importance of each variable.All children improved and were discharged following treatment with azithromycin/doxycycline (1/99). Twelve variable features were identified through the LASSO regression. Of the six predictive models developed, the XGBoost model demonstrated the highest performance in the training set (AUC = 0.926), though its performance in the test set was moderate (AUC = 0.740). The MLP model exhibited robust predictive performance in both training and test sets, with AUCs of 0.897 and 0.817, respectively. Clinical decision curve analysis indicated that the MLP and XGBoost models provide significant clinical utility. SHAP analysis identified the most important predictors for STME as ferritin, white blood cell count, edema, prothrombin time, fibrinogen, duration of pre-admission fever, eschar, activated partial thromboplastin time, splenomegaly, and headache. The MLP and XGBoost models showed strong predictive capability for pediatric STME, with favorable outcomes following doxycycline-based therapy.
             </div>
            </div>
            <!--]-->
            <!--]-->
           </div>
           <!-- -->
          </div>
         </div>
         <!--]-->
        </div>
       </div>
      </div>
     </div>
     <!--]-->
    </div>
    <div class="_container_8x5ka_1 _literatureCard_nf4fx_1 mt-3" data-testid="literature-document-card">
     <!-- -->
     <!--[-->
     <div class="_container_afoc1_1 border">
      <div class="_subTitle_afoc1_14">
       <!--[-->
       <div class="flex flex-col flex-wrap md:flex-row md:items-center md:justify-start">
        <span data-testid="literature-document-card__publication-data">
         01 Dec 2025
        </span>
        <span class="mx-1 hidden md:block">
         ·
        </span>
        <span class="mr-2 text-black" data-testid="literature-document-card__journal-name">
         JOURNAL OF CLINICAL IMMUNOLOGY
        </span>
        <!-- -->
       </div>
       <!--]-->
      </div>
      <div class="mt-2 flex items-start">
       <div class="flex-1 overflow-hidden">
        <div class="flex">
         <div>
          <div class="_title_afoc1_6">
           <!--[-->
           <div class="inline-flex max-w-full">
            <div class="_tipsContainer_b7pjb_1 _normal_b7pjb_23" dialogtype="common" entrancetype="text" isallinforegister="false" showjumptip="true" size="medium" style="--28c9148e:4px;" type="default">
             <!--[-->
             <!--]-->
             <!-- -->
             <!--[-->
             <!--[-->
             <span class="_title_nf4fx_1" data-testid="literature-document-card__title">
              Restitutio ad integrum: Rescuing the Alveolar Macrophage Function with HSCT in Pulmonary Alveolar Proteinosis Due to CSF2Rα Deficiency
             </span>
             <!--]-->
             <!--]-->
            </div>
           </div>
           <!--]-->
          </div>
          <!--[-->
          <!--]-->
         </div>
         <!-- -->
        </div>
        <div class="_content_afoc1_31">
         <!--[-->
         <div class="md:hidden">
          <!-- -->
         </div>
         <div class="hidden md:block">
          <div class="flex">
           <span class="_tag_5lm5p_1 _default_5lm5p_20 _small_5lm5p_31 mr-2" style="background:#EDF8FF;color:#0170BD;">
            <!--[-->
            Article
            <!--]-->
           </span>
           <!-- -->
          </div>
          <div class="mt-3 line-clamp-3" data-testid="literature-document-card__author">
           Author:
           <!--[-->
           <span>
            Pandrowala, Ambreen
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Mishra-Sopori, Varsha
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Khan, Sanaa
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Bodhanwala, Minnie
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Hiwarkar, Prashant
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Chandane, Parmarth
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Khosla, Indu
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Kataria, Darshan
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Sehgal, Kunal
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Prabhudesai, Pralhad
            <!-- -->
           </span>
           <!--]-->
          </div>
          <div class="_container_16a6u_1 _containerStyle_16a6u_7 mt-3" data-testid="literature-document-card__abstract" style="--374e759f:100px;--661d8904:#1976d2;--470d35e6:20px;--78a7937a:20px;--cab18e14:#1976d2;--324c64a8:#1976d2;--8277a0b4:0px;">
           <div>
            <!--[-->
            <!--[-->
            <div class="text-text-t2 whitespace-pre-wrap break-words text-sm leading-5">
             <span class="float-left mr-1">
             </span>
             <div class="text-black-default text-sm" style="word-break:break-word;">
              Hereditary pulmonary alveolar proteinosis (hPAP) is a rare lung-related primary immunodeficiency. In hPAP, variants of genes encoding the heterodimeric GM-CSF receptor alpha or beta-chains (CSF2Rα, CSF2Rβ) lead to perturbations in GM-CSF signalling. These perturbations impair the scavenging function of pulmonary alveolar macrophages leading to accumulation of surfactant proteins and lipids within the alveoli. The replacement of defective pulmonary alveolar macrophages can be achieved with allogeneic hematopoietic stem cell transplantation. However, previous reports highlight undesirable pulmonary outcomes associated with this therapeutic approach. We report a 4-year-old developmentally normal girl born of second-degree consanguineous marriage diagnosed with severe form of CSFRα-deficient PAP. She required recurrent whole lung lavage and hence was treated with allogeneic hematopoietic stem cell transplantation. A reduced toxicity treosulfan-based myeloablative regimen with alemtuzumab serotherapy was used for conditioning. Ciclosporin, mycophenolate mofetil and FAM (fluticasone inhaler, azithromycin, montelukast) were used to prevent graft-versus-host disease and immune-related complications of lung. Her post-transplant course was uneventful with full donor chimerism and complete resolution of symptoms. We demonstrate for the first time in a case of severe CSF2Rα-deficient PAP, the successful use of hematopoietic stem cell transplantation as a primary curative treatment, restoring normal lungs both anatomically and functionally. The case report provides evidence for considering allogeneic hematopoietic stem cell transplant in severe forms of CSF2R-deficient PAP.
             </div>
            </div>
            <!--]-->
            <!--]-->
           </div>
           <!-- -->
          </div>
         </div>
         <!--]-->
        </div>
       </div>
      </div>
     </div>
     <!--]-->
    </div>
    <div class="_container_8x5ka_1 _literatureCard_nf4fx_1 mt-3" data-testid="literature-document-card">
     <!-- -->
     <!--[-->
     <div class="_container_afoc1_1 border">
      <div class="_subTitle_afoc1_14">
       <!--[-->
       <div class="flex flex-col flex-wrap md:flex-row md:items-center md:justify-start">
        <span data-testid="literature-document-card__publication-data">
         01 Aug 2025
        </span>
        <span class="mx-1 hidden md:block">
         ·
        </span>
        <span class="mr-2 text-black" data-testid="literature-document-card__journal-name">
         COMPUTATIONAL BIOLOGY AND CHEMISTRY
        </span>
        <!-- -->
       </div>
       <!--]-->
      </div>
      <div class="mt-2 flex items-start">
       <div class="flex-1 overflow-hidden">
        <div class="flex">
         <div>
          <div class="_title_afoc1_6">
           <!--[-->
           <div class="inline-flex max-w-full">
            <div class="_tipsContainer_b7pjb_1 _normal_b7pjb_23" dialogtype="common" entrancetype="text" isallinforegister="false" showjumptip="true" size="medium" style="--28c9148e:4px;" type="default">
             <!--[-->
             <!--]-->
             <!-- -->
             <!--[-->
             <!--[-->
             <span class="_title_nf4fx_1" data-testid="literature-document-card__title">
              Modulating Acinetobacter baumannii BfmR (RstA) drug target: Daniellia oliveri compounds as RstA quorum sensing inhibitors
             </span>
             <!--]-->
             <!--]-->
            </div>
           </div>
           <!--]-->
          </div>
          <!--[-->
          <!--]-->
         </div>
         <!-- -->
        </div>
        <div class="_content_afoc1_31">
         <!--[-->
         <div class="md:hidden">
          <!-- -->
         </div>
         <div class="hidden md:block">
          <div class="flex">
           <span class="_tag_5lm5p_1 _default_5lm5p_20 _small_5lm5p_31 mr-2" style="background:#EDF8FF;color:#0170BD;">
            <!--[-->
            Article
            <!--]-->
           </span>
           <!-- -->
          </div>
          <div class="mt-3 line-clamp-3" data-testid="literature-document-card__author">
           Author:
           <!--[-->
           <span>
            Dweba, Yamkela
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Aruwa, Christiana E
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Sabiu, Saheed
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Ayodele, Oladunni M
            <!-- -->
           </span>
           <!--]-->
          </div>
          <div class="_container_16a6u_1 _containerStyle_16a6u_7 mt-3" data-testid="literature-document-card__abstract" style="--374e759f:100px;--661d8904:#1976d2;--470d35e6:20px;--78a7937a:20px;--cab18e14:#1976d2;--324c64a8:#1976d2;--8277a0b4:0px;">
           <div>
            <!--[-->
            <!--[-->
            <div class="text-text-t2 whitespace-pre-wrap break-words text-sm leading-5">
             <span class="float-left mr-1">
             </span>
             <div class="text-black-default text-sm" style="word-break:break-word;">
              Plant products have been integral to the derivation of interventive therapies to mitigate the current scourge of antimicrobial resistance (AMR). The South African plant, Daniellia oliveri, may yet hold promise against WHO-listed critical priority pathogens like Acinetobacter baumannii and its quorum sensing (QS) system, BfmR (RstA). Hence, we bio-prospected D. oliveri compounds in a bid to provide alternative antimicrobial therapeutics, specifically, potential quorum sensing inhibitors (QSIs). This study utilized a range of in silico validated tools for the cheminformatic analysis of RstA modulating properties of D. oliveri-associated compounds. The two (2) lead compounds identified (β-carotene, β-amyrin) had docking scores of -6.8 kcal/mol, relative to -6.7 kcal/mol observed for the azithromycin reference. Only cis-Calamenene and β-amyrin had pharmacokinetic features conformed to the rule of 5 (Ro5) for selection as potential oral drug candidates. β-carotene and rutin had the best quantum reactivity attributes (lowest energy gap, and highest electronegativity and global electrophilicity). Molecular dynamics (MD) simulation revealed that all lead ligands bound to RstA stabilized system compactness and thermodynamics. Although the azithromycin-RstA system had the least ∆G
              <sub>
               bind
              </sub>
              (-40.48 kcal/mol), rutin had the next highest ∆G
              <sub>
               bind
              </sub>
              (-31.53 kcal/mol) of all D. oliveri compounds. Overall, these lead Daniellia oliveri metabolites may yet have potential RstA inhibitory/modulatory action upon further structural modification, and in vitro and in vivo validation tests prior to formulation into oral, interventive QSIs targeting A. baumannii RstA modulation.
             </div>
            </div>
            <!--]-->
            <!--]-->
           </div>
           <!-- -->
          </div>
         </div>
         <!--]-->
        </div>
       </div>
      </div>
     </div>
     <!--]-->
    </div>
    <!--]-->
   </div>
   <div class="mt-10 md:mt-12">
    <div class="mb-4 break-all text-sm text-black">
     <div class="inline-flex max-w-full">
      <!--[-->
      <span class="cursor-pointer font-semibold text-seo-blue-500 underline" data-testid="related-news-count">
       42
      </span>
      <!--]-->
     </div>
     <span>
      News (Medical) associated with Azithromycin
     </span>
    </div>
    <!--[-->
    <div class="_container_8x5ka_1 _newsCard_1m6m5_1" data-testid="news-document-card">
     <!-- -->
     <!--[-->
     <div class="_container_afoc1_1 border">
      <div class="_subTitle_afoc1_14">
       <!--[-->
       <span class="">
        26 Mar 2025
       </span>
       <div class="hidden md:inline-block">
        <span class="px-1">
         ·
        </span>
        <a class="text-blue-500" href="https://pipelinereview.com/blujepa-gepotidacin-approved-by-us-fda-for-treatment-of-uncomplicated-urinary-tract-infections-uutis-in-female-adults-and-pediatric-patients-12-years-of-age-and-older/" rel="nofollow noopener" target="_blank">
         <!--[-->
         pipelinereview.com
         <!--]-->
        </a>
       </div>
       <!--]-->
      </div>
      <div class="mt-2 flex items-start">
       <div class="flex-1 overflow-hidden">
        <div class="flex">
         <div>
          <div class="_title_afoc1_6">
           <!--[-->
           <a data-testid="news-document-card__title" href="https://pipelinereview.com/blujepa-gepotidacin-approved-by-us-fda-for-treatment-of-uncomplicated-urinary-tract-infections-uutis-in-female-adults-and-pediatric-patients-12-years-of-age-and-older/" rel="noopener" target="_blank">
            <!--[-->
            <span class="_title_1m6m5_1">
             Blujepa (gepotidacin) Approved by US FDA for Treatment of Uncomplicated Urinary Tract Infections (uUTIs) in Female Adults and Pediatric Patients 12 Years of Age and Older
            </span>
            <!--]-->
           </a>
           <!--]-->
          </div>
          <!--[-->
          <div class="_container_16a6u_1 _containerStyle_16a6u_7 mt-2 hidden text-sm text-grey-450 md:block" style="--374e759f:60px;--661d8904:#1976d2;--470d35e6:20px;--78a7937a:20px;--cab18e14:#1976d2;--324c64a8:#1976d2;--8277a0b4:0px;">
           <div>
            <!--[-->
            <div data-testid="news-document-card__content" style="word-break:break-word;">
             PHILADELPHIA, PA, USA I March 25, 2025 I
GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved
Blujepa
(gepotidacin) for the treatment of female adults (≥40 kg) and pediatric patients (≥12 years, ≥40 kg) with uncomplicated urinary tract infections (uUTIs) caused by the following susceptible microorganisms:
Escherichia coli
,
Klebsiella pneumoniae
,
Citrobacter freundii
complex,
Staphylococcus saprophyticus
and
Enterococcus faecalis
.
Discovered by GSK scientists,
Blujepa
is a first-in-class oral antibiotic with a novel mechanism of action that is part of GSK’s infectious diseases portfolio.
Tony Wood, Chief Scientific Officer, GSK, said
: “The approval of
Blujepa
is a crucial milestone with uUTIs among the most common infections in women. We are proud to have developed
Blujepa
, the first in a new class of oral antibiotics for uUTIs in nearly three decades, and to bring another option to patients given recurrent infections and rising rates of resistance to existing treatments.”
uUTIs are the most common infection in women, impacting up to 16 million women in the US annually.
1-4
Over half of all women are affected by uUTI in their lifetime,
5
with approximately 30% suffering from at least one recurrent episode which can cause significant patient burden, including discomfort and restriction of daily activities.
6
New treatments are needed as the number of uUTIs caused by drug-resistant bacteria is increasing which can result in higher treatment failure rates.
7
Thomas Hooton, MD, Professor of Clinical Medicine, University of Miami School of Medicine said:
“For many, uUTIs can be a burden that severely impacts daily life. With an increasing number of patients experiencing recurrent infections, there remains a clear need for continued research of antimicrobials to help address ongoing patient challenges and the strain on healthcare systems.”
The approval is based on positive results from the pivotal phase III EAGLE-2 and EAGLE-3 trials which demonstrated non-inferiority to nitrofurantoin, one of the leading current standard of care options for uUTI, in female adults (≥40 kg) and pediatric patients (≥12 years, ≥40 kg) with a confirmed uUTI. In EAGLE-2,
Blujepa
demonstrated non-inferiority in therapeutic success which occurred in 50.6% (162/320) of participants compared to 47.0% (135/287) for nitrofurantoin (covariate-adjusted treatment difference 4.3%, 95% CI (-3.6, 12.1)). In EAGLE-3,
Blujepa
demonstrated statistically significant superiority versus nitrofurantoin (one-sided p-value 0.0003). Therapeutic success occurred in 58.5% (162/277) of participants compared to 43.6% (115/264) for nitrofurantoin (covariate-adjusted treatment difference 14.6%, 95% CI (6.4, 22.8)).
The safety and tolerability profile of
Blujepa
in the EAGLE-2 and EAGLE-3 phase III trials was consistent with previous trials. The most commonly reported adverse events (AEs) in
Blujepa
participants were gastrointestinal (GI). Diarrhea was the most common (16% of participants), followed by nausea (9%). Of the participants who reported GI AEs in the
Blujepa
group, the most common maximum severity was mild (69% Grade 1) and moderate (28% Grade 2). Participants with Grade 3 GI events accounted for 3% of all patients with GI events and occurred in &lt;1% of all participants. There was one drug-related serious adverse event in each treatment arm (
Blujepa
and nitrofurantoin) across the two trials.
US commercial launch is planned in 2H 2025.
The development of
Blujepa
(gepotidacin) has been funded in part with federal funds from the US Department of Health and Human Services, Administration for Strategic Preparedness and Response, Biomedical Advanced Research and Development Authority (BARDA), under Other Transaction Agreement number HHSO100201300011C and with federal funds awarded by the Defense Threat Reduction Agency under agreement number HDTRA1-07-9-0002.
About
Blujepa
(gepotidacin)
Blujepa
, discovered by GSK scientists, is a bactericidal, first-in-class triazaacenaphthylene antibiotic that inhibits bacterial DNA replication by a distinct binding site, a novel mechanism of action and for most pathogens, provides well-balanced inhibition of two different Type II topoisomerase enzymes. This provides activity against most target uropathogens (such as
Escherichia coli
and
Staphylococcus saprophyticus
), and
Neisseria gonorrhoeae
, including isolates resistant to current antibiotics. Due to the well-balanced inhibition for most pathogens,
Blujepa
target-specific mutations in both enzymes are needed to significantly affect susceptibility to
Blujepa
. Therefore, a lower potential for resistance development is expected. Efficacy and safety in patients have been demonstrated in uUTI and gonorrhea phase III clinical trials, including in patients with drug-resistant pathogens.
Please see full Prescribing Information including Medication Guide,
available here
.
About the EAGLE (Efficacy of Antibacterial Gepotidacin Evaluated) phase III program
The global phase III clinical program for
Blujepa
(gepotidacin) in adults and pediatric patients consists of three trials:
EAGLE-2 and EAGLE-3 (non-inferiority uUTI trials) compared the efficacy and safety of
Blujepa
(1,500mg administered orally twice daily for five days) to nitrofurantoin (100mg administered orally twice daily for five days) with 1531 and 1605 female adults and pediatric patients with uUTIs, respectively. Across both trials, the planned duration of follow-up for participants was approximately 28 days, and the primary endpoint, a stringent composite measure of efficacy, was the combined clinical and microbiological response at the Test-of-Cure (ToC) visit (days 10-13) in patients with qualifying uropathogens susceptible to nitrofurantoin.
EAGLE-1 (non-inferiority uncomplicated urogenital gonorrhea trial) compared the efficacy and safety of
Blujepa
to ceftriaxone plus azithromycin in 628 patients with uncomplicated urogenital gonorrhea caused by
N. gonorrhoeae
.
GSK in infectious diseases
GSK has pioneered innovation in infectious diseases for over 70 years, and the Company’s pipeline of medicines and vaccines is one of the largest and most diverse in the industry, with a goal of developing preventive and therapeutic treatments for multiple disease areas or diseases with high unmet needs globally. Our expertise and capabilities in infectious disease strongly position us to help prevent disease and mitigate the challenge of antimicrobial resistance (AMR).
In antimicrobials, in addition to gepotidacin, GSK entered into an exclusive license agreement with Spero Therapeutics, Inc. in September 2022 to add tebipenem HBr, a late-stage antibiotic and potential treatment for complicated urinary tract infections (cUTIs), to the pipeline and are currently enrolling for PIVOT-PO, a phase III trial. In March 2023, GSK announced an exclusive license agreement with Scynexis for
Brexafemme
(ibrexafungerp tablets), a first-in-class antifungal for the treatment of vulvovaginal candidiasis (VVC) and reduction in the incidence of recurrent VVC.
BLUJEPA (gepotidacin) tablets, for oral use
Indication(s) and Important Safety Information (ISI)
INDICATION
BLUJEPA is indicated for the treatment of female adult and pediatric patients 12 years of age and older weighing at least 40 kilograms (kg) with uncomplicated urinary tract infections (uUTI) caused by the following susceptible microorganisms:
Escherichia coli
,
Klebsiella pneumoniae
,
Citrobacter freundii
complex,
Staphylococcus saprophyticus
, and
Enterococcus faecalis
.
Usage to Reduce Development of Drug-Resistant Bacteria
To reduce the development of drug-resistant bacteria and maintain the effectiveness of BLUJEPA and other antibacterial drugs, BLUJEPA should be used only to treat infections that are proven or strongly suspected to be caused by bacteria.
About GSK
GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at
gsk.com
.
References
1
Advani SD, et al. Poster presented at: ISPOR 2024; May 5-8, 2024. Presentation EPH17.
2
Foxman B, et al. Urinary tract infection: self-reported incidence and associated costs.
Ann Epidemiol
. 2000;10(8):509-15.
3
Foxman B. Urinary Tract Infection Syndromes: Occurrence, Recurrence, Bacteriology, Risk Factors, and Disease Burden.
Infect Dis Clin North Am
. 2014 28(1):1-13.
4
United States Census Bureau. Age and Sex Composition: 2020. [Available from:
https://www2.census.gov/library/publications/decennial/2020/census-briefs/c2020br-06.pdf
Last accessed March 2025].
5
Czajkowski, K, et al. Urinary tract infection in women.
Prz Menopauzalny
. 2021;20(1):40-7.
6
Little P, et al. Presentation, pattern, and natural course of severe symptoms, and role of antibiotics and antibiotic resistance among patients presenting with suspected uncomplicated urinary tract infection in primary care: observational study.
BMJ
. 2010;340:b5633.
7
Kaye KS, et al. Antimicrobial resistance trends in urine Escherichia coli isolates from adult and adolescent females in the United States from 2011 to 2019: rising ESBL strains and impact on patient management.
Clin Infect Dis
2021;73:1992–1999.
SOURCE:
GlaxoSmithKline
            </div>
            <!--]-->
           </div>
           <!-- -->
          </div>
          <!--]-->
         </div>
         <!-- -->
        </div>
        <div class="_content_afoc1_31">
         <!--[-->
         <div class="inline-flex max-w-full mt-2 flex flex-wrap justify-start">
          <!--[-->
          <div data-testid="news-document-card__tag">
           <!--[-->
           <span class="_tag_5lm5p_1 _success_5lm5p_15 _small_5lm5p_31 mb-1 mr-2 cursor-pointer" data-testid="news-document-card__tag__item" style="background:;color:;">
            <!--[-->
            Phase 3
            <!--]-->
           </span>
           <span class="_tag_5lm5p_1 _success_5lm5p_15 _small_5lm5p_31 mb-1 mr-2 cursor-pointer" data-testid="news-document-card__tag__item" style="background:;color:;">
            <!--[-->
            Clinical Result
            <!--]-->
           </span>
           <span class="_tag_5lm5p_1 _success_5lm5p_15 _small_5lm5p_31 mb-1 mr-2 cursor-pointer" data-testid="news-document-card__tag__item" style="background:;color:;">
            <!--[-->
            License out/in
            <!--]-->
           </span>
           <span class="_tag_5lm5p_1 _success_5lm5p_15 _small_5lm5p_31 mb-1 mr-2 cursor-pointer" data-testid="news-document-card__tag__item" style="background:;color:;">
            <!--[-->
            Drug Approval
            <!--]-->
           </span>
           <!--]-->
          </div>
          <!--]-->
         </div>
         <!--]-->
        </div>
       </div>
      </div>
     </div>
     <!--]-->
    </div>
    <div class="_container_8x5ka_1 _newsCard_1m6m5_1 mt-3" data-testid="news-document-card">
     <!-- -->
     <!--[-->
     <div class="_container_afoc1_1 border">
      <div class="_subTitle_afoc1_14">
       <!--[-->
       <span class="">
        15 Nov 2024
       </span>
       <div class="hidden md:inline-block">
        <span class="px-1">
         ·
        </span>
        <a class="text-blue-500" href="https://www.echemi.com/cms/2120149.html" rel="nofollow noopener" target="_blank">
         <!--[-->
         www.echemi.com
         <!--]-->
        </a>
       </div>
       <!--]-->
      </div>
      <div class="mt-2 flex items-start">
       <div class="flex-1 overflow-hidden">
        <div class="flex">
         <div>
          <div class="_title_afoc1_6">
           <!--[-->
           <a data-testid="news-document-card__title" href="https://www.echemi.com/cms/2120149.html" rel="noopener" target="_blank">
            <!--[-->
            <span class="_title_1m6m5_1">
             Pfizer Plans to Sell Hospital Drug Division, 35% of Chinese Market to Change Hands
            </span>
            <!--]-->
           </a>
           <!--]-->
          </div>
          <!--[-->
          <div class="_container_16a6u_1 _containerStyle_16a6u_7 mt-2 hidden text-sm text-grey-450 md:block" style="--374e759f:60px;--661d8904:#1976d2;--470d35e6:20px;--78a7937a:20px;--cab18e14:#1976d2;--324c64a8:#1976d2;--8277a0b4:0px;">
           <div>
            <!--[-->
            <div data-testid="news-document-card__content" style="word-break:break-word;">
             On November 12, Reuters reported that US pharmaceutical giant Pfizer plans to sell its hospital drugs unit and is currently working with Goldman Sachs to evaluate it. The move means that the products, including antibiotics, steroids and immunoglobulins, will change owners, including the original drug Supraxen, which has a 35 percent market share in China.
Pfizer's hospital drugs unit is an asset it acquired after acquiring Hospira for $17 billion in 2015. Less than a decade later, however, Pfizer was willing to put it up for sale, and it is interesting why.
It is speculated that the pressure behind this decision may come from investment institutions. The Starboard Value fund made a strategic investment in Pfizer this year, and according to data from the Wall Street Journal, it now holds a $1 billion stake in the company, enough to influence Pfizer's management decisions. Starboard's chief financial officer has repeatedly called on Pfizer to optimize internal capital allocation, liquidate some of its assets and put more money into areas with more potential.
Pfizer's hospital pharmaceuticals division includes anti-infective drugs and sterile injections, including well-known antibiotics Supraxen, Sfortol and Zithromax, steroids Medrol and immunoglobulin product Panzyga, and is currently part of its specialty pharmaceuticals business. In 2023, the division contributed billions of dollars in revenue to Pfizer and maintained a 15% growth rate. However, from the perspective of the capital market, such a growth rate still seems to fall short of expectations.
Pfizer is widely expected to make further changes to its business segments in the future. Under the significant impact of the Starboard Value fund on Pfizer's strategic layout, Pfizer's core business may also face significant changes, which adds a considerable degree of uncertainty to the company's future development. On November 13, Pfizer's share price was slightly affected, falling nearly 3% at one point.
            </div>
            <!--]-->
           </div>
           <!-- -->
          </div>
          <!--]-->
         </div>
         <!-- -->
        </div>
        <div class="_content_afoc1_31">
         <!--[-->
         <div class="inline-flex max-w-full mt-2 flex flex-wrap justify-start">
          <!--[-->
          <div data-testid="news-document-card__tag">
           <!--[-->
           <span class="_tag_5lm5p_1 _success_5lm5p_15 _small_5lm5p_31 mb-1 mr-2 cursor-pointer" data-testid="news-document-card__tag__item" style="background:;color:;">
            <!--[-->
            Acquisition
            <!--]-->
           </span>
           <!--]-->
          </div>
          <!--]-->
         </div>
         <!--]-->
        </div>
       </div>
      </div>
     </div>
     <!--]-->
    </div>
    <div class="_container_8x5ka_1 _newsCard_1m6m5_1 mt-3" data-testid="news-document-card">
     <!-- -->
     <!--[-->
     <div class="_container_afoc1_1 border">
      <div class="_subTitle_afoc1_14">
       <!--[-->
       <span class="">
        12 Aug 2024
       </span>
       <div class="hidden md:inline-block">
        <span class="px-1">
         ·
        </span>
        <a class="text-blue-500" href="https://www.drugs.com/news/some-cases-recurrent-wheeze-kids-may-need-new-120735.html" rel="nofollow noopener" target="_blank">
         <!--[-->
         www.drugs.com
         <!--]-->
        </a>
       </div>
       <!--]-->
      </div>
      <div class="mt-2 flex items-start">
       <div class="flex-1 overflow-hidden">
        <div class="flex">
         <div>
          <div class="_title_afoc1_6">
           <!--[-->
           <a data-testid="news-document-card__title" href="https://www.drugs.com/news/some-cases-recurrent-wheeze-kids-may-need-new-120735.html" rel="noopener" target="_blank">
            <!--[-->
            <span class="_title_1m6m5_1">
             Some Cases of Recurrent Wheeze in Kids May Need New Treatment
            </span>
            <!--]-->
           </a>
           <!--]-->
          </div>
          <!--[-->
          <div class="_container_16a6u_1 _containerStyle_16a6u_7 mt-2 hidden text-sm text-grey-450 md:block" style="--374e759f:60px;--661d8904:#1976d2;--470d35e6:20px;--78a7937a:20px;--cab18e14:#1976d2;--324c64a8:#1976d2;--8277a0b4:0px;">
           <div>
            <!--[-->
            <div data-testid="news-document-card__content" style="word-break:break-word;">
             MONDAY, Aug. 12, 2024  -- Does your kid suffer from wheezing that returns again and again?
They might be suffering from a “silent” viral lung infection that would be better treated by changing up their medications, a new study finds.
Nearly a quarter of children and teens with severe wheezing have undetected lung infections, researchers reported recently in the
Journal of Allergy and Clinical Immunology
.
Unfortunately, these infections won’t respond to corticosteroids commonly used to treat wheezing, researchers said.
In fact, higher doses of steroids might put children at higher risk of lingering lung inflammation, as well as other known side effects of those drugs.
“While steroids can help some children with wheeze, many children in the study showed no patterns of inflammation that would improve with steroids,” said lead researcher
Dr. Gerald Teague
, a pediatric pulmonologist with the University of Virginia School of Medicine.
Instead, these kids should be treated with medications that target viruses and symptoms of viral infection, Teague said.
“I advise the parents of my patients that have wheeze episodes that are triggered by colds should be treated with anti-inflammatory medications that build immunity to viruses, such as
azithromycin
,” Teague said in a university news release.
"They look surprised that we would use an antibiotic for a viral infection, but, in fact, azithromycin bolsters the immune response to viruses in a positive way,” Teague added.
For the study, researchers screened more than 800 children and teens with severe and persistent wheezing -- a whistling or rattling sound that occurs while breathing.
Rhinoviruses -- the main cause of the common cold -- can trigger wheezing episodes, but wheezing more often is treated the same as asthma, researchers said. In
asthma
, inhaled corticosteroids are used to reduce airway inflammation.
But the results showed that 22% of children with recurrent wheezing were indeed suffering from silent viral infections.
Researchers aren’t sure why these kids can’t shake off these infections, which also can involve other types of viruses.
They suspect something may be going awry in the immune cells of the children’s lungs, so that they are unable to fight off these viruses.
Notably, the problem seems to primarily affect very young children, researchers said. By the time they reach school age, viral-associated wheezing becomes less common.
Doctors should rethink how they treat recurrent wheezing and explore potential causes before prescribing powerful corticosteroids, Teague said.
“Viral infections are the most important trigger of acute wheeze episodes in children and, in some cases, lead to respiratory distress and hospital care,” Teague said.
“We hope this discovery will stimulate further work in the treatment of recurrent wheeze and viral infections in children,” Teague added. “The field has to get to away from overuse of potentially toxic steroids for the treatment of acute wheeze to include novel therapies which target specific patterns of inflammation.”
Whatever your topic of interest,
subscribe to our newsletters
to get the best of Drugs.com in your inbox.
            </div>
            <!--]-->
           </div>
           <!-- -->
          </div>
          <!--]-->
         </div>
         <!-- -->
        </div>
        <div class="_content_afoc1_31">
         <!--[-->
         <div class="inline-flex max-w-full mt-2 flex flex-wrap justify-start">
          <!--[-->
          <div data-testid="news-document-card__tag">
           <!--[-->
           <span class="_tag_5lm5p_1 _success_5lm5p_15 _small_5lm5p_31 mb-1 mr-2 cursor-pointer" data-testid="news-document-card__tag__item" style="background:;color:;">
            <!--[-->
            Clinical Result
            <!--]-->
           </span>
           <!--]-->
          </div>
          <!--]-->
         </div>
         <!--]-->
        </div>
       </div>
      </div>
     </div>
     <!--]-->
    </div>
    <!--]-->
   </div>
   <div class="mt-10 md:mt-12">
    <div class="mb-4 break-all text-sm text-black">
     <!--[-->
     <span class="_mosaic_dzucl_1">
      <!--[-->
      <span class="font-semibold text-seo-blue-500 underline">
       100
      </span>
      <!--]-->
     </span>
     <!--]-->
     <span>
      Deals associated with Azithromycin
     </span>
    </div>
    <div class="inline-flex max-w-full mt-4 w-full">
     <div class="_tipsContainer_b7pjb_1 _yellow_b7pjb_30 _tipsBorder_b7pjb_9" dialogtype="common" entrancetype="text" isallinforegister="false" showjumptip="true" size="medium" style="--28c9148e:4px;" type="default">
      <!--[-->
      <!--]-->
      <svg class="h-4 w-[10px]" fill="currentColor" height="1.2em" viewbox="0 0 10 16" width="1.2em">
       <path d="M9.70678 6.27142H5.92999L6.67408 0.15021C6.68107 0.0907286 6.65118 0.0334335 6.60111 0.0103023C6.55104 -0.0128288 6.49315 0.00392205 6.45976 0.0512057L0.0610803 9.20641C-0.00721034 9.30424 -0.0192403 9.43647 0.0300607 9.54737C0.0793617 9.65827 0.181418 9.72854 0.293217 9.72858H4.07001L3.32592 15.8498C3.31893 15.9093 3.34882 15.9666 3.39889 15.9897C3.44896 16.0128 3.50685 15.9961 3.54024 15.9488L9.93892 6.79359C10.0072 6.69576 10.0192 6.56353 9.96994 6.45263C9.92064 6.34174 9.81858 6.27146 9.70678 6.27142Z" fill-rule="evenodd">
       </path>
      </svg>
      <!--[-->
      <span class="_text_b7pjb_17">
       Login to view more data
      </span>
      <!--]-->
     </div>
    </div>
   </div>
   <!--]-->
  </div>
 </div>
 <div class="_item2_gldt3_15" id="external">
  <h3 class="_title_gldt3_1">
   <span>
    External Link
   </span>
  </h3>
  <div class="_content_gldt3_7">
   <!--[-->
   <div class="ant-table-wrapper" style="">
    <div class="ant-spin-nested-loading">
     <!-- -->
     <div class="ant-spin-container">
      <!--[-->
      <div class="ant-table ant-table-small ant-table-bordered" style="">
       <!-- -->
       <div class="ant-table-container">
        <div class="ant-table-content" style="">
         <table style="table-layout:auto;">
          <colgroup>
           <!--[-->
           <col style="width:25%;"/>
           <col style="width:25%;"/>
           <col style="width:25%;"/>
           <col style="width:25%;"/>
           <!--]-->
          </colgroup>
          <thead class="ant-table-thead">
           <!--[-->
           <tr>
            <!--[-->
            <th class="ant-table-cell" colend="0" colstart="0" style="">
             <!-- -->
             KEGG
             <!--[-->
             <!-- -->
             <!--]-->
            </th>
            <th class="ant-table-cell" colend="1" colstart="1" style="">
             <!-- -->
             Wiki
             <!--[-->
             <!-- -->
             <!--]-->
            </th>
            <th class="ant-table-cell" colend="2" colstart="2" style="">
             <!-- -->
             ATC
             <!--[-->
             <!-- -->
             <!--]-->
            </th>
            <th class="ant-table-cell" colend="3" colstart="3" style="">
             <!-- -->
             Drug Bank
             <!--[-->
             <!-- -->
             <!--]-->
            </th>
            <!--]-->
           </tr>
           <!--]-->
          </thead>
          <tbody class="ant-table-tbody">
           <!-- -->
           <!--[-->
           <!--[-->
           <tr class="ant-table-row ant-table-row-level-0" style="">
            <!--[-->
            <td class="ant-table-cell" style="">
             <!-- -->
             <span>
              <!--[-->
              <!--[-->
              <a class="mr-1 text-seo-blue-500" href="https://www.genome.jp/entry/dr:D07486" rel="nofollow noopener" target="_blank">
               <!--[-->
               D07486
               <!--]-->
              </a>
              <!--]-->
              <!--]-->
             </span>
             <!-- -->
            </td>
            <td class="ant-table-cell" style="">
             <!-- -->
             <span>
              <!--[-->
              <a class="text-seo-blue-500" href="https://en.wikipedia.org/wiki/Azithromycin" rel="nofollow noopener" target="_blank">
               <!--[-->
               Azithromycin
               <!--]-->
              </a>
              <!--]-->
             </span>
             <!-- -->
            </td>
            <td class="ant-table-cell" style="">
             <!-- -->
             <span>
              <!--[-->
              <div class="flex flex-wrap">
               <!--[-->
               <a class="mr-1 text-seo-blue-500" href="https://www.whocc.no/atc_ddd_index/?code=J01FA10&amp;showdescription=yes" rel="nofollow noopener" target="_blank">
                <!--[-->
                J01FA10
                <!--]-->
               </a>
               <a class="mr-1 text-seo-blue-500" href="https://www.whocc.no/atc_ddd_index/?code=S01AA26&amp;showdescription=yes" rel="nofollow noopener" target="_blank">
                <!--[-->
                S01AA26
                <!--]-->
               </a>
               <!--]-->
              </div>
              <!--]-->
             </span>
             <!-- -->
            </td>
            <td class="ant-table-cell" style="">
             <!-- -->
             <span>
              <!--[-->
              <div class="flex flex-wrap">
               <!--[-->
               <a class="mr-1 text-seo-blue-500" href="https://go.drugbank.com/drugs/DB00207" rel="nofollow noopener" target="_blank">
                <!--[-->
                DB00207
                <!--]-->
               </a>
               <!--]-->
              </div>
              <!--]-->
             </span>
             <!-- -->
            </td>
            <!--]-->
           </tr>
           <!-- -->
           <!--]-->
           <!--]-->
          </tbody>
          <!-- -->
         </table>
        </div>
       </div>
       <!-- -->
      </div>
      <!--]-->
     </div>
    </div>
   </div>
   <!--]-->
  </div>
 </div>
</div>
